Podcasts about bavarian nordic

President Trump has been on a staff cutting rampage since taking office, and this weekend, the hammer came down on an undisclosed number of FDA employees. The firings—which reportedly affected staffers within the FDA's centers for food, medical devices and tobacco products—came days after Robert F. Kennedy Jr. was confirmed as HHS secretary.One space that could have an ally in RFK Jr. is psychedelic therapies, which the new HHS boss has accused the FDA of “suppressing,” along with stem cell therapies. On the flip side, Kennedy is a well-known vaccine critic, though his confirmation didn't affect the approvals of a pair of vaccines—one for GSK's meningococcal shot and another for Bavarian Nordic's chikungunya jab.One notable vaccine maker, however, is struggling. Moderna reported Q4 and 2024 earnings last week, revealing full-year revenue of just over $3 billion—less than half of the nearly $7 billion the company brought in the year before. Adding insult to financial injury, Moderna is also laying off around 50 employees on its digital team.Moderna isn't the only company facing challenges. Several biopharmas, including Merck, Regeneron and Bristol Myers Squibb are facing patent headwinds that, according to William Blair, are the strongest they've been in nearly 15 years. It's also a difficult climate in which to stay alive as a biotech, to which the 13 bankruptcies in 2024 can attest.Finally, BioSpace launched a new NextGen podcast series this week, in which senior editor Annalee Armstrong speaks with execs from four of our NextGen Class of 2025 companies—starting with COUR Pharmaceuticals.

This week on Careers in Discovery, we're joined by Tommi Kainu, Chairman of GlyProVac, a Biotech developing bacterial vaccines with the potential to tackle antimicrobial resistance. Tommi's career has taken him from medicine and research to consulting at BCG and leadership roles in Biotech. He shared insights on GlyProVac's work, why commercial thinking is key in drug development, and lessons from his time at Bavarian Nordic - including the unexpected rise of the MPOX vaccine. His advice for scientists moving into industry? Start with the end in mind. A great conversation on science, strategy, and the business of Biotech.

I takt med flere geopolitiske konflikter som krigen i Ukraine oplever storbanker cyberangreb, der ifølge bankcheferne skal tages meget alvorligt. Der er landet grøn trepartsaftale med bred politisk opbakning i Folketinget. På trods af svingende aktiekurser og uvisheder ser topchef hos Bavarian Nordic, Paul Chaplin, lyst på fremtiden. Vært: Trine Duvander (trdu@borsen.dk)

(+FLSmidths farvel til cement og Falcks Jakob Riis' syn på sundhedsreform) "The dream is collapsing" - så måske er det på tide, at Bavarian Nordic bliver en del af noget større? Det kunne investeringsøkonom Per Hansen godt være tilbøjelig til at mene, når han er med i studiet for at tygge Bavarian Nordics regnskab igennem - og pege på de udfordringer, som biotek-virksomheder står overfor. Der bliver også tid til at gå tilbage i historien. FLSmidths frasalg af cementforretningen nærmer sig. Så Ulrik og Sune dykker ned i ingeniørvirksomhedens historie - fra cement, over verdenskrige, arve-kontrakt til minedrift. Hvad er det, de siger farvel til? Og til sidst ringer vi til Falcks CEO Jakob Riis. Der er nemlig landet en sundhedsreform - og spørgsmålet er nu, om han kan se forretningsmuligheder i planerne for det kommende sundhedsvæsen? Vært: Ulrik Rosenkvist Schultz. Fast gæst: Sune Aagaard. Medvirkende: Per Hansen, investeringsøkonom hos Nordnet og Jakob Riis, CEO hos Falck.

La Comisión Europea ha presentado este viernes las nuevas previsiones económicas de otoño que sitúan el crecimiento del PIB de media de la UE tan solo en un 0,9% y un 0,8% para la zona euro. Previsiones que se cerraron a finales de octubre y que no tienen en cuenta las posibles consecuencias de una nueva presidencia de Donald Trump. El comisario de Asuntos Económicos, el italiano Paolo Gentiloni, recuerda que "a pesar de las disputas comerciales, EEUU y Europa comparten el interés por mantener normas estrictas, una competencia leal y la estabilidad en los mercados mundiales". Por países, vuelve a destacar el crecimiento de España del 3% en 2024. También hemos conocido el PIB del Reino Unido del tercer trimestre que apenas crece un 0,1%, muy por debajo del 0,5% registrado en los tres meses anteriores. Malas noticias para los fabricantes europeos de vacunas tras elegir Donald Trump a Robert Kennedy Jr para dirigir el Departamento de Salud. Bavarian Nordic, que fabrica una vacuna contra la viruela del simio, baja casi un 17% espera que EEUU aumente la financiación en biodefensa. Hablaremos con Ludovic Pierre Duprat, director del Hotel Park Piolets Mountain Hotel & Spa en Soldeu de la oferta de Andorra para la próxima escapada de invierno. En Expansión y Ciclo, casi 1.200 empresas han solicitado un ERTE por fuerza mayor por la DANA mientras el presidente de la Generalitat valenciana, Carlos Mazón, comparece en el Parlamento para dar explicaciones sobre la gestión de la DANA y pedir disculpas a los que se sintieron abandonados. Temas que abordaremos en la Tertulia de Cierre de Mercados con Juan Iranzo, catedrático de Economía Aplicada de la UNED, e Iñigo Petit, ceo de iDen Global.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Sanofi has signed a $326 million deal with Orano Med for radiopharma, following a similar deal made in September. Sage Therapeutics is laying off 33% of employees to support the launch of its postpartum depression drug. Bristol-Myers Squibb's Opdivo showed a progression-free survival advantage over Pfizer's Adcetris in a late-stage study for Hodgkin's lymphoma. Kezar Life Sciences has cut its lupus program after patient deaths and is now focusing on autoimmune hepatitis. The Institute for Clinical Research is researching ways to extend healthy lifespan. Other news includes GSK and Viiv touting the effectiveness of a long-acting HIV prep, Bavarian Nordic's Jynneos eliciting a robust antibody response in adolescents, and AbbVie winning approval for an advanced Parkinson's treatment. Takeda has walked away from a partnership for Huntington's disease after investing $260 million.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.CVS is laying off 2,900 employees as part of a cost-cutting plan and potential business breakup. Humana's Medicare Advantage star ratings have dropped significantly, impacting profits. Healthcare workers face burnout, while the payer-provider relationship is evolving. Mission Hospital in North Carolina is struggling after Hurricane Helene, and Steward CEO Ralph de la Torre is being sued by senators. Healthcare companies are urged to prioritize patient-centric experiences. The text also highlights upcoming healthcare conferences, telehealth trends, and insights into the relationship between providers and payers.The FDA has officially declared the end of the shortage of Zepbound and Mounjaro, putting pressure on companies selling compounded alternatives. Biopharma conferences in 2025 are important for showcasing clinical trial results. The FDA is set to make several key decisions in the fourth quarter, including approving a rival to a popular Pfizer heart drug. Roche plans to address an $8 billion sales gap due to biosimilar competition. Lilly is investing $4.5 billion in a "foundry" for advanced drug manufacturing. Additionally, there are resources available on topics such as AI in clinical research, genetic screening, gene therapy, and biosimilars. Other industry news includes potential sales of pharma units by Chinese company Wuxi, and the US's commitment to African manufacturing in HIV programs.Sanofi has sold the global rights to a rare autoimmune drug for cold agglutinin disease to Recordati in a potential $1 billion deal. Recordati will make an upfront payment of $825 million to Sanofi, with milestone payments of up to $250 million. Meanwhile, Novo's lowest dose of Wegovy remains on the FDA's drug shortage list. AbbVie has trimmed its full-year earnings guidance due to R&D milestone costs, following the success of its Parkinson's disease candidate Tavapadon. Relay Therapeutics is laying off 10% of its workforce to streamline its research organization. The pharma industry is prioritizing scaling GLP-1 manufacturing capacity to meet the demand for weight loss drugs. Lilly has ended its obesity drug shortage, while Novo continues to face shortages. WBL's proprietary library prep for cfDNA whole genome sequencing aims to enhance specificity, sensitivity, and data quality at low concentrations. In other news, BMS has received FDA approval for an Opdivo regimen in NSCLC and Bavarian Nordic's MPox shot shows antibody responses wane after 6 to 12 months.Dr. Matthew Schrag, a vascular neurologist at Vanderbilt University, is not prescribing the new Alzheimer's disease treatments, Kisunla and Leqembi, due to concerns over risks and costs. Schrag has a history of challenging prevailing science in Alzheimer's and has exposed instances of potential misconduct by researchers. In 2021, he raised allegations of data manipulation against Cassava Sciences, leading to ongoing scrutiny and calls for their phase 3 trials to be stopped. Despite distancing himself from the controversy, Schrag's findings have had a significant impact on the company. The article also discusses Roivant's unique approach to drug development, the latest advances in oncology research, and the challenges in navigating the path from preclinical studies to regulatory approval for gene therapies. The text highlights the importance of efficient therapeutic development processes and increasing diversity in clinical trials. Additionally, it provides links to resources on selecting clinical trial sites, unlocking partnerships for small biotech firms, and optimizing AAV manufacturing processes. The newsletter also includes updates on Medicare drug price talks, a groundbreaking trial for lung cancer treatment, and a map of a fruit fly's brain that has impressed neuroscientists.

A OMS (Organização Mundial de Saúde) declarou a Mpox como Emergência de Saúde Pública de Importância Internacional (ESPII) em agosto e os países agora se preparam para a chegada da nova variante da doença, o clado 1b. Ele foi identificado em julho na República do Congo e está se propagando rapidamente.  Taíssa Stivanin, da RFI em ParisCerca de um milhão de doses da vacina Jynneo, desenvolvida pelo laboratório dinamarquês Bavarian Nordic, devem ser encaminhadas em breve para conter o surto na região. Em todo o continente africano, já foram oficialmente diagnosticados cerca de 5 mil casos, de acordo com as últimas estimativas - 20 mil se os dados consideram as infecções "prováveis".Até o momento, o Brasil ainda não registrou contaminações com o novo subtipo, mas desde o início do ano, foram registradas mais de 800 infecções da outra variante, a clado-2, que se espalhou em 2022. Por que a nova linhagem é considerada mais preocupante pela OMS e qual a diferença entre os dois subtipos? A RFI Brasil conversou sobre o novo surto de Mpox com o virologista Olivier Schwartz, diretor do Departamento de Vírus e Imunologia do Instituto Pasteur, em Paris.Segundo ele, poucos casos de infecções do subtipo clado 1b, que já chegou à Europa, foram descritos pela comunidade científica. Na Suécia, uma pessoa que voltava da República do Congo foi testada positiva em agosto. Desde então, os pesquisadores do país analisam o caso para dividir as informações em nível europeu, explica o virologista francês.“O paciente foi atendido e as amostras analisadas e sequenciadas. Os pesquisadores suecos agora estão tentando 'ampliar' o vírus para poder estudá-lo, analisar suas características e dividir os dados com outros laboratórios, entre eles o Instituto Pasteur", detalhou o especialista.Na França, as autoridades reforçaram os diagnósticos e preparam a campanha de vacinação. O Instituto Pasteur é um dos cerca de 200 centros preparados para aplicar as doses, e poderá também realizar o teste PCR que confirma a infecção. Segundo o cientista, apesar do sistema de saúde francês estar em alerta e preparado desde o primeiro surto de Mpox em 2022, a expectativa é que não haja uma explosão do número de casos, devido à imunidade adquirida pela população. Antes de 1980 a vacinação contra a varíola, um vírus da mesma família do Mpox, era obrigatória. Além disso, parte da população considerada a risco na época foi imunizada em 2022. Uma das questões agora é estabelecer a eficácia do imunizante, que contém um vírus vivo atenuado, ou seja, enfraquecido, contra a infecção pelo novo subtipo. “Sabemos que a vacina é eficaz contra o clado 1 em testes com animais, feitos em laboratório, e em testes celulares. Mas por enquanto, a eficácia contra o novo subtipo ainda é desconhecida. Mas, sabendo como o imunizante funciona e conhecendo o sequenciamento do vírus clado 1, esperamos que a vacina possa combatê-lo. Os estudos mostram uma eficácia de 70% a 90% de redução de infecções graves após duas doses”.Clado x VarianteQual a diferença entre um clado e uma variante? De acordo com Olivier Schwartz, o clado é um grupo de vírus e uma variante é uma “cepa em particular”. Segundo ele, “no caso do Mpox, esses grupos são definidos por análises de sequências genômicas. Percebemos, ao reconstituir a árvore filogenética, ou seja, a árvore genealógica dos vírus que circulavam, que existiam dois ramos principais: o grupo ou clado 1 e o grupo ou clado 2. Eles são próximos”.Segundo o virologista do Instituto Pasteur, também não há grandes diferenças entre os dois clados em termos de mortalidade, apesar do clado 1 ser um pouco mais virulento. O cientista lembra que é difícil saber em que proporção as condições sanitárias ou ambientais contribuem para o aumento do número de formas graves da doença.TransmissãoO vírus Mpox é transmitido principalmente através do contato próximo e prolongado com pessoas doentes que tenham bolhas, feridas, erupções cutâneas, crostas e fluidos, como secreção e sangue. O Ministério da Saúde alerta que objetos recentemente contaminados também podem transmitir a doença.Já a carga viral presente na saliva expelida quando duas pessoas conversam, por exemplo, é bem menor. “Provavelmente há casos, mas talvez não seja a principal forma de transmissão. Por hora, não temos evidências. Que eu saiba, não há provas de que o clado 1b é transmitido de maneira eficaz pela respiração”, esclarece o virologista.A transmissão do vírus por pessoas assintomáticas também ainda não foi confirmada. Segundo Olivier Schwartz, é possível que pessoas vacinadas contra a varíola no passado desenvolvam formas extremamente leves da doença e possam ser contagiosas, mas essa hipótese deve ser confirmada por estudos comparativos de carga viral.Pacientes imunossuprimidos correm mais risco de desenvolver formas graves e, nessa situação, o diagnóstico é fundamental para evitar complicações. A prevenção passa pelo isolamento rápido dos casos positivos. Os sintomas aparecem entre 3 e 21 dias após a contaminação e incluem, além das erupções cutâneas, febre alta, dor de cabeça e cansaço. Pais de crianças pequenas devem ficar atentos para não confundir a doença com a Catapora, que provoca o aparecimento de bolhas parecidas. Por isso é importante realizar o diagnóstico o mais cedo possível.Antiviral está sendo testadoDe acordo com o virologista francês, o antiviral Tecovirimat está sendo testado contra a doença. Estudos mostram que ele pode acelerar a cicatrização das lesões, mas exigem aprofundamento, já que os primeiros resultados foram decepcionantes.“Sabemos que é uma molécula antiviral que funciona muito bem nos modelos animais e em cultura celular nos laboratórios. Então é muito cedo para saber se, no homem, a falta de eficácia demonstrada no estudo está relacionada a outros parâmetros”.Entre esses parâmetros, o especialista do Instituto Pasteur cita o momento do início da terapia e compara com o Paxlovid, um dos antivirais usados contra o vírus da Covid-19. Para frear a infecção e a transmissão, ele deve ser prescrito entre dois e três dias após a contaminação.

Wiki-Trader Christian Scheid setzt auf Zertifikate als Absicherung. So kam er vergleichsweise gut durch die Korrekturen, wobei ihn auch eine relativ hohe Cashquote seit Anfang 2022 unterstützte. Neun Aktien, darunter Covestro, HelloFresh, Globalstar, Emergent BioSolutions und Bavarian Nordic, befinden sich im Wikifolio Special Situations long/short ( https://go.brn-ag.de/361 ), das ist eine Quote von 30 %. "Für mich ist kein Unternehmen der Welt 3 Billionen wert", so Christian Scheid beim Derivatetag des Bundesverbands für strukturierte Wertpapiere BSW in Frankfurt über Nvidia und den KI-Zug, "für mich ist die Blase geplatzt." Ein Vorteil für den Wiki-Trader Scheid: Er war nach oben nicht dabei, muss jetzt aber auch nicht den Weg mit nach unten gehen.

Hvis man får ondt i maven, når aktierne ruller ned ad bakke, så havde man nok mavepine i aftes.   Der var nemlig aktiefald på menuen -  især i USA - hvor chipgiganten Nvidia tog det største endages fald målt på børsværdi nogensinde.   Men hvad udløste faldet, og kommer det til at fortsætte? Det ser vi nærmere på her i onsdagens udgave af Millionærklubben.   Vi skal også forbi Bavarian Nordic samt Ørsted, der begge stjal rampelyset i den danske andedam tirsdag.   Dagens panel er Lars Hytting, aktiechef i ArthaScopa og Michael Friis, aktiechef i HC Andersen Capital og porteføljeforvalter i Millionærklubben.   Vært: Signe TerpSee omnystudio.com/listener for privacy information.

Quinze jours après que l'OMS a déclenché son plus haut degré d'alerte face à la résurgence des cas de Mpox en Afrique, l'épidémie continue de progresser sur le continent. La RDC reste de loin le pays le plus touché, mais l'épidémie s'étend. Treize autres pays présentent désormais des cas suspects. Plusieurs États ont promis d'envoyer prochainement des doses de vaccins. Quand ces doses seront-elles livrées ? En quelles quantités ? À quand la fabrication de vaccins sur le continent ? Entretien avec Jean Kaseya, le directeur général d'Africa CDC, le Centre de contrôle et de prévention des maladies de l'Union africaine. RFI : le Mpox poursuit sa progression sur le continent. L'Africa CDC fait état de près de 23 000 cas suspects détectés au 27 août et plus de 600 décès. Est-ce que ces chiffres vous inquiètent ?Jean Kaseya : Ces chiffres m'inquiètent au plus haut point, puisque ça prouve ce que nous disons tous les jours, que nous avons plusieurs épidémies Mpox en une. Pourquoi nous le disons, c'est puisque nous avons quatre variants qui se côtoient aujourd'hui en Afrique et qui ont des épidémiologies différentes, qui ont des symptomatologies qui se présentent dans les différents groupes d'âges et qui aujourd'hui n'ont pas suffisamment de recul en termes de médicaments et en termes de mesures applicables comme les vaccins et autres. Donc, ça m'inquiète au plus haut point.La RDC reste, et de loin, le pays le plus touché. Est-ce que c'est là où la progression est la plus forte ces derniers jours ?La progression est forte dans plusieurs provinces de la RDC. Mais la progression, on la voit aussi dans d'autres pays africains comme le Burundi, comme la RCA. Mais je dois dire, ce qui m'inquiète le plus, c'est que nous avons des pays qui sont non endémiques, mais qui ont rapporté pour la première fois des cas de Mpox comme le Gabon. Le ministre de la Sierra Leone m'informait aujourd'hui [mercredi 28 août], qu'il a eu un cas qui lui semble patent pour Mpox. Mais comme la Sierra Leone n'a pas de laboratoire fiable, il ne peut pas confirmer cela. Et donc moi, je considère, sur base de la symptomatologie, sur base de l'histoire de la maladie, que c'est un cas suspect de Mpox. Et je classe la Sierra Leone maintenant comme un nouveau pays qui est le 14e pays affecté par le Mpox.Plusieurs pays ont promis d'envoyer des doses de vaccin au continent. Quelle sera l'ampleur de ces livraisons ?Je voudrais reconnaître l'effort que les partenaires d'Afrique ont fait pour jusque-là, sécuriser les vaccins que nous avons. Nous avons d'abord, avec la branche humanitaire de l'Union européenne, sécurisé 215 000 doses. À cela s'ajoute les 100 000 doses que la France vient de donner par le même mécanisme de l'Union européenne et Africa CDC. En plus, nous avons 100 000 doses qui viendront de l'Allemagne. Mais je dois saluer le gouvernement espagnol, puisque l'Espagne donne 500 000 doses de vaccins. À ces doses-là qui représentent à peu près 1 million de doses, nous savons que Gavi est aussi en train de travailler avec nous, pour disponibiliser autour de 500 000 doses. Donc, nous pouvons dire qu'à ce stade, nous partons déjà autour de 1,5 ou 1,6 million de doses, sur les 10 millions que nous voulons avoir.À quelle échéance ces doses seront-elles livrées au continent ?Les vaccins que nous avons déjà eus, par exemple les 215 000 doses sont disponibles même à partir de demain. Ce que nous voulons, avant que les vaccins arrivent aux pays, c'est qu'il y ait une bonne logistique qui soit en place. Donc, je suis en train d'espérer et de travailler, comme je pense que le niveau de préparation des pays est assez optimal, que la semaine prochaine, les premières doses des vaccins sécurisés par Africa CDC, dans le mécanisme que nous avons mis en place, vont atterrir dans les différents pays.Mais combien de doses, précisément, pourraient arriver dès la semaine prochaine ?Nous allons commencer graduellement, et ça, c'est important que la population africaine le sache : nous avons décidé, à Africa CDC, de faire en sorte que ce qui s'est passé avec le Covid n'arrive plus. Donc, l'accord que nous avons avec la société Bavarian Nordic qui produit ces vaccins, c'est que cette année, ils vont nous donner 3 millions de doses. Mais ils vont aussi faire le transfert des technologies pour que ce vaccin soit produit sur le continent africain, par les compagnies africaines. Nous avons déjà un accord et nous avons déjà sélectionné la société qui pourrait faire cette production. Nous pensons que d'ici février, la société africaine qui a été sélectionnée sera en mesure d'inonder le marché africain avec le vaccin Mpox.À lire aussiMpox: pourquoi l'accès aux vaccins est problématique en Afrique?

On this week's Biotech Hangout, hosts Brad Loncar, Tim Opler, Josh Schimmer and Sam Fazeli assess the recent macro trends, including the current state of the US economy and some good news for biotech. The group also discussed the big reveal this week on Medicare drug pricing issues and industry perspectives on whether it was more of a whimper versus a bang. In M&A, the Revance and Crown Laboratories merger was discussed as well as broader M&A trends including how a potential change in the White House could impact the FTC and scrutiny on pharma deals. In other news, the hosts shared differing perspectives on Genentech shutting down its cancer immunology group and the company's wider R&D prioritization. The group also discussed the World Health Organization declaring MPOX a global health emergency and the vaccines in development from Bavarian Nordic, Moderna and BioNTech. Other topics covered on this episode include Zealand's earnings, positive data from Rivus and Denali, a look ahead at The World Conference on Lung Cancer (WCLC) and European Society for Medical Oncology (ESMO) and more. *This episode aired on August 16, 2024.

Ulrik har lavet sin helt egen Sorte-tal-AI undersøgelse. Ser de danske C25-virksomheder umiddelbart flest muligheder eller risici ved brugen af kunstig intelligens? Regnskaberne bliver ved med at vælte ind for de store danske C25-virksomheder - og i den her omgang vender vi Coloplast, Rockwool, GN Store Nord, Jyske Bank og Bavarian Nordic, som de seneste uger har oplevet en voldsom interesse for deres mpox-vaccine. Rutschebanerne i Tivoli er barnemad i forhold til det, som virksomheden oplever. Og bare rolig! Skulle du ikke være helt skarp på reglerne i C25-kvartalregnskabspoker, så forklarer vi dem igen efter en lytterhenvendelse. Dem kan vi i øvrigt godt lide, så fang os endelig på sortetal@dr.dk - eller diverse sociale medier. Vært: Ulrik Rosenkvist Schultz. Fast gæst: Sune Aagaard. Medvirkende: Lars Christensen, CEO hos Paice og Per Hansen, investeringsøkonom hos Nordnet.

In der heutigen Folge von „Alles auf Aktien“ sprechen die Finanzjournalisten Anja Ettel und Holger Zschäpitz über den plötzlichen Shootingstar Peloton, Turnaround-Fantasie für die Kitkat-Aktie und warum Tesla plötzlich alt aussieht. Außerdem geht es um Nestlé, CTS Eventim, Bavarian Nordic, Lucid, Zoom, Snowflake, Workday, Nvidia, AMD, Intel, Stillfront Group, Ubisoft Entertainment, Take-Two Interactive, Microsoft, Nintendo, Eletcronic Arts, und VanEck Video Gaming and eSports (WKN: A2PLDF). Wir freuen uns an Feedback über aaa@welt.de. Ab sofort gibt es noch mehr "Alles auf Aktien" bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem bei WELT: Im werktäglichen Podcast „Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Bullische Stimmung an den Märkten

Det er friske regnskabstal på banen torsdag og udmeldinger fra bl.a. Bavarian Nordic, GN Store Nord og Gubra. Millionærklubben ser på sagerne og debatterer selskabernes fremtidsmuligheder med senior analytiker Søren Løntoft fra Sydbank på telefonen og i studiet Lau Svenssen og Michelle Nørgaard. Vært: Bodil Johanne Gantzel. See omnystudio.com/listener for privacy information.

Dagens erhvervsoverblik: Både hos Danfoss og Grundfos kæmper man med lavere efterspørgsel - og det får konsekvenser. Liberal Alliance vil reformere pensionssystemet. Ford skrotter elbilssats. Jobvæksten nedjusteres i USA. Federal Reserve klar til rentesænkning. Bavarian Nordic falder igen. Vært: Lasse Ladefoged (lala@borsen.dk)

In der heutigen Folge von „Alles auf Aktien“ sprechen die Finanzjournalisten Anja Ettel und Holger Zschäpitz über AMDs Angriff auf Nvidia, Monster-Rallye für mpox-Aktien und eine Mega-Fusion im Späti-Markt. Außerdem geht es um Rheinmetall, Hensoldt, Renk, Bayer, Estée Lauder, AMD, Nvidia, Virax, Bavarian Nordic, GeoVax Labs, Seven & i Holding, Alimentation Couche-Tard, Palo Alto, Monster, Celsius, Crowdstrike, Varta, Porsche, Voltabox, Morphosys, Novartis, Singulus, Delivery Hero, Bike24 Holding, Douglas, Brain Biotech, Mister Spex, Vita34, TUI, AboutYou, RWE, E.On, Siltronic, Deutsche Telekom, Villeroy und Boch, Thyssenkrupp, Bilfinger, Siemens Healthineers, Rheinmetall, Schott Pharma, SAP, Nemetschek, Vanguard FTSE All World (WKN: A2PKXG), Xtrackers MSCI World ex USA (WKN: DBX0VH), Invesco EQQQ Nasdaq 100 ETF (WKN: 801498) und iShares Core S&P 500 ETF (WKN: A0YEDG). Wir freuen uns an Feedback über aaa@welt.de. Ab sofort gibt es noch mehr "Alles auf Aktien" bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem bei WELT: Im werktäglichen Podcast „Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.On August 19, 2024, the FDA approved the first at-home syphilis test by NowDiagnostics, providing quick results with just a drop of blood. Dupont acquired Donatelle Plastics for $313 million, while Boston Scientific resubmitted its merger filing for Silk Road Medical. Edwards invested in Genesis Medtech and Biden pledged $150 million for medical technology to enhance cancer surgery. The biotech industry is active, with companies gearing up for the DSCSA deadline and utilizing multiple trial technologies. In the biopharma industry, Bristol Myers' schizophrenia drug is nearing approval, a partial hold was lifted on a Biontech-partnered ADC study, Novo Nordisk plans to build a new plant, and Medicare drug price cuts are impacting pharma profits. Patient-centric commercialization strategies are on the rise, along with concerns about Medicare price cuts affecting drug research and patent protection measures.Bristol Myers Squibb's KarXT faces a PDUFA date for potential approval as a new schizophrenia treatment. AbbVie's Emraclidine also shows promise as a gut-friendly option for schizophrenia patients. Market strategies beyond FDA approval are being explored to ensure successful drug launch and adoption in the competitive landscape.The FDA has cleared Biontech-Medilink's Phase I ADC cancer trial after a partial hold, while Liquidia missed full approval for a pulmonary hypertension drug. Bavarian Nordic is ramping up vaccine production in response to a global health emergency. Developers remain optimistic about psychedelic therapies despite setbacks like Lykos' rejection. Other updates include advancements in various therapeutic spaces and industry shifts such as layoffs.Texas hospitals secured a victory in a lawsuit on low-income payment formulas. Employer healthcare costs are expected to rise due to inflation and specialty drugs. Healthcare bankruptcies have slowed down but financial challenges persist. Payers are leveraging digital technology to improve outcomes and prepare for regulatory changes like the DSCSA deadline. Healthcare organizations are focusing on patient-centric care, combating burnout, and adapting to trends like telehealth and value-based care.In conclusion, the Pharma and Biotech industry is evolving rapidly with advancements in technology, regulatory changes, and shifting market dynamics shaping its future trajectory. Stay tuned for more updates on the latest developments in this dynamic sector.

Hvad vil den nye kvantecomputer kunne, når den er færdigudviklet? Hvad sagde Joe Biden på sin tale ved Det Demokratiske Konvent? Og hvordan kan danske Bavarian Nordic med sin vaccine stoppe udbredelsen af Mpox? Dagens værter: Pernille Rudbæk og Kristian Magnus Damsgaard.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Medicare has revealed the results of drug price negotiations, showing $6 billion in savings for taxpayers from talks involving drugs like Eliquis and Xarelto. Lilly has opened an R&D hub in Boston, while Ovid and Lexicon are facing layoffs. A journal has retracted papers on MDMA-assisted therapy, and Evotec is cutting jobs and exiting gene therapy. Galderma has received FDA approval for a skin condition treatment, and trends in cell therapy research and market strategies of pharma giants are being explored. The impact of AI technology on clinical trials, patient-centric commercialization strategies, and upcoming events in the biopharma industry are also discussed.Texas is suing the Biden administration over a nursing home staffing mandate requiring at least 3.48 hours of care per resident each day. A report accuses HCA of driving away doctors and downgrading care at Mission Hospital after acquiring it. Medicare drug price cuts may have limited early impact but could have bigger future implications for drug research. Nurses may need their own AI documentation tools due to complex work and shifting tasks. Additionally, Medicaid has overtaken Medicare Advantage as a concern for health insurers in the second quarter. The text also includes information on updating healthcare sales approaches and using data to improve patient outcomes.Pfizer and BioNTech's COVID-flu shot candidate faced setbacks in Phase III trials, potentially giving Moderna an advantage with its superior vaccine. Medicare negotiated drug prices touted by the Biden-Harris administration are criticized as hollow victories. Other news includes Lycos slashing its workforce, Bavarian Nordic's potential windfall with an emergency vaccine, and AstraZeneca's Imfinzi scoring FDA approvals. Layoff announcements in the biopharma industry are also highlighted. The role of Quality Assurance and Regulatory Affairs (QARA) professionals in market access is explored.Walmart's ad unit has experienced significant growth, with ad sales from marketplace sellers increasing by nearly 50% in fiscal Q2. The digital economy is expected to expand, particularly in online retail and online travel. Marketers are increasingly turning to first-party data strategies and behavioral data to enhance their marketing efforts. Industry Dive provides insights and news for marketing leaders, covering topics such as brand strategy, social media, video marketing, and more. Companies can post press releases on Marketing Dive to share announcements with a wide audience.

Aktien hören ist gut. Aktien kaufen ist besser. Bei unserem Partner Scalable Capital geht's unbegrenzt per Trading-Flatrate oder regelmäßig per Sparplan. Alle weiteren Infos gibt's hier: scalable.capital/oaws. Aktien + Whatsapp = Hier anmelden. Lieber als Newsletter? Geht auch.  Das Buch zum Podcast? Jetzt lesen. Es war die beste Woche seit 2023 für den S&P 500, es war eine Woche mit 500 Milliarden Wertzuwachs für NVIDIA, es war eine Woche mit Mpox-Ausbruch für Bavarian Nordic. Ansonsten rettet ein Etikett Bayer und niemand rettet die Kleinanleger von Varta. Turbinen sind der heiße Scheiß. Davon profitieren Rolls-Royce, Mitsubishi Heavy Industries und Siemens Energy. Aber einer profitiert noch mehr: Howmet Aerospace (WKN: A2PZ2D). Denn: Auch Schaufelverkäufer brauchen Schaufelverkäufer. Websites sind der heiße Scheiß. Natürlich nicht! GoDaddy (WKN: A14QAF) boomt trotzdem. Diesen Podcast vom 19.08.2024, 3:00 Uhr stellt dir die Podstars GmbH (Noah Leidinger) zur Verfügung.

 - Tổng Bí thư, Chủ tịch nước Tô Lâm và Phu nhân cùng đoàn đại biểu cấp cao Việt Nam lên đường thăm cấp Nhà nước tới Cộng hòa Nhân dân Trung Hoa.- Thủ tướng Phạm Minh Chính phát động đợt thi đua cao điểm "500 ngày đêm thi đua hoàn thành 3.000km đường bộ cao tốc".- Đường dây 500kv mạch 3 Nam Định 1 – Phố Nối đang gấp rút hoàn thiện những công đoạn cuối cùng, quyết tâm đóng điện an toàn vào ngày mai.- Mùa vu lan rằm tháng 7 trở thành nét văn hóa để mỗi người thể hiện lòng hiếu hạnh, uống nước nhớ nguồn, tri ân công ơn cha mẹ và những người đã khuất.- Ít nhất 15 người Palestin thiệt mạng do trúng không kích ở Trung Gaza, trong khi Liên hợp quốc tiếp tục quan ngại về việc quân đội Israel đưa ra nhiều lệnh sơ tán mới đối với người dân Palestine.- Hãng dược phẩm Bavarian Nordic tăng cường sản xuất vắc xin phòng bệnh đậu mùa khỉ, đảm bảo tất cả các nước có thể tiếp cận công bằng đối với loại vaccine này. Chủ đề : Tổng Bí thư, Chủ tịch nước, Tô Lâm, Phu nhân, Trung Hoa --- Support this podcast: https://podcasters.spotify.com/pod/show/vov1thoisu0/support

- Hãng dược phẩm Bavarian Nordic vừa thông báo kế hoạch tăng cường sản xuất vaccine phòng bệnh đậu mùa khỉ và đang phối hợp với các tổ chức y tế quốc tế để đảm bảo tiếp cận công bằng đối với loại vaccine này. Công ty đưa ra thông báo này sau khi Tổ chức Y tế thế giới (WHO) ban bố tình trạng khẩn cấp về sức khỏe cộng đồng trên toàn cầu do bệnh đậu mùa khỉ bùng phát ở các nước châu Phi. Chủ đề : sản xuất, vaccine, phòng bệnh, đậu mùa khỉ --- Support this podcast: https://podcasters.spotify.com/pod/show/vov1tintuc/support

In der heutigen Folge von „Alles auf Aktien“ sprechen die Finanzjournalisten Anja Ettel und Philipp Vetter über die Kauflaune bei Walmart, Rückenwind für Nike und einen neuen Starlink-Konkurrenten. Außerdem geht es um Cisco, Berkshire Hathaway, Heico, Sirius XM, Bavarian Nordic, Alibaba, JD.com, Baywa, AST SpaceMobile, AT&T, Verizon, SpaceX, Amazon, Home Depot, Apple, Alphabet, Hyundai, OpenAI, Microsoft, BMW, Tesla, den iShares Automation & Robotics (WKN: A2ANH0) und den Amundi MSCI Robotics & AI ESG Screened (WKN: A2JSC9). Der iShares Core MSCI World ETF (Acc) (WKN: A0RPWH) ist der thesaurierende ETF und der iShares MSCI World ETF (Dist) (WKN: A0HGV0) ist die ausschüttende Variante. Wir freuen uns an Feedback über aaa@welt.de. Ab sofort gibt es noch mehr "Alles auf Aktien" bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem bei WELT: Im werktäglichen Podcast „Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Ørsted skuffer igen investorerne med stor nedskrivning og aktien dykker. Bavarian Nordic sprudler på børsen efter mpox-udbrud. Boligpriser steg bredt hen over sommeren. Mette Frederiksens udspil kan være starten på udfasningen af SVM. Walz og Vance skal mødes i debat. Detailsalg overrasker positivt i USA og aktierne fortsætter op. Vært: Lasse Ladefoged (lala@borsen.dk)  

Join Michelle Martin on her tour of markets! Michelle Martin with Ryan Huang dive into  Grab's mixed earnings performance as SingTel posts strong profits. In China, Alibaba struggles while JD.com thrives, and Walmart raises its outlook following a stellar quarter. Discover Warren Buffet's latest moves, including investments in Ulta Beauty and Apple, and hear about Bavarian Nordic's surge amid a healthcare rally. Michelle also breaks down gains in UOB Kay Hian, Tapestry, and Sri Trang Gloves, with local market highlights from ST Engineering and City Developments.  See omnystudio.com/listener for privacy information.

06:07: Iran lovede hævn for attentat på Hamas-leder i Iran. Men præstestyret har været stille, og nu er der 'lovende' fredsforhandlinger mellem Israel og Hamas, lyder det fra USA. Medvirkende: Allan Sørensen, mellemøstkorrespondent for Kristeligt Dagblad. 06:21: Den norske krone falder og falder. Hvad sker der? Medvirkende: Kim Blindbæk, Seniorøkonom i Sydbank. 06:33: Kamala Harris skal til at fremlægge reel politik og balancere på et hårfint strå, når hun gør det. Medvirkende: Marcus Rubin, kronikredaktør på Politiken og tidligere USA-korrespondent. 06:45: Hvornår går grænsen: er det etisk korrekt at tjene penge på en sygdom? Medvirkende: Helge Larsen, Redaktør på Proinvestor.com, investor og forfatter, og Steven Kjær, aktieinvestor i Bavarian Nordic. Værter: Silas Moody og Mathias WissingSee omnystudio.com/listener for privacy information.

In this episode, we discuss the newest pandemic and those profiting from the vaccines, the election illusion, and much more. Rumble: https://rumble.com/c/TheFactHunter Website: thefacthunter.com Email: thefacthunter@mail.com Snail Mail: George Hobbs PO Box 109 Goldsboro, MD  21636Show Notes:Gold https://www.nasdaq.com/articles/sky-high-gold-prices-are-sending-a-warning-about-war.-pay-attention. HHS United States Government's Response to the Clade I Mpox Outbreak https://www.hhs.gov/about/news/2024/08/14/united-states-governments-response-clade-i-mpox-outbreak-democratic-republic-congo-other-countries-region.html Bavarian Nordic scores $157M contract to replenish US supplies of smallpox/mpox vaccine Jynneos https://www.fiercepharma.com/pharma/bavarian-nordic-scores-1568m-contract-replenish-us-supplies-combination-smallpoxmpox-vaccine#:~:text=Following%20the%20commercial%20launch%20of,agreement%20with%20the%20U.S.%20government. https://jynneos.com In an Oligarchy, Voting is a Tool to Manufacture the Illusion of Consent https://www.activistpost.com/2016/10/oligarchy-voting-tool-manufacture-illusion-consent.html Who Owns America? Oligarchs Hav

Unser Partner Scalable Capital ist der einzige Broker, den du brauchst. Inklusive Trading-Flatrate, Zinsen und Portfolio-Analysen. Alle weiteren Infos gibt's hier: scalable.capital/oaws. Aktien + Whatsapp = Hier anmelden. Lieber als Newsletter? Geht auch.  Das Buch zum Podcast? Jetzt lesen.  Victoria's Secret steigt wegen neuer Chefin. Rheinmetall und Kellanova steigen wegen Übernahmen. Der norwegische Staatsfonds und Mars haben extrem viel Geld. UBS hat Investmentbanker, Bavarian Nordic hat Bestellungen & Inflation ist niedrig. MSCI World ist kein Welt-ETF. Das weiß hoffentlich jeder. Aber macht's überhaupt Sinn, die ganze Welt im Depot zu haben? Wir klären auf. Worldcoin ist vielleicht die Zukunft der Kryptowelt. Falls das so ist, spielt Jena in dieser Zukunft eine Rolle. Genauer gesagt: Jabil (WKN: 886423). Diesen Podcast vom 15.08.2024, 3:00 Uhr stellt dir die Podstars GmbH (Noah Leidinger) zur Verfügung.

Unser Partner Scalable Capital ist der einzige Broker, den du brauchst. Inklusive Trading-Flatrate, Zinsen und Portfolio-Analysen. Alle weiteren Infos gibt's hier: scalable.capital/oaws. Aktien + Whatsapp = Hier anmelden. Lieber als Newsletter? Geht auch. Das Buch zum Podcast? Jetzt lesen. Der Auto- und Tourismus-Branche geht's nicht gut. Wissen wir alle. Continental und Disney haben es nochmal bestätigt. Keine Bestätigung gab's für Novo Nordisk, Evotec und Puma. Umso besser ging's Fortinet, Axon und Shopify. Mpox (früher Affenpocken) breitet sich leider wieder aus. Bavarian Nordic (WKN: 917165) hat den Impfstoff dafür. Coinbase (WKN: A2QP7J) profitiert, wenn die Krypto-Kurse steigen. Das letzte Quartal hat das Gegenteil bewiesen. Einige Lichtblicke gab's trotzdem. Diesen Podcast vom 08.08.2024, 3:00 Uhr stellt dir die Podstars GmbH (Noah Leidinger) zur Verfügung.

In der heutigen Folge von “Alles auf Aktien” sprechen die Finanzjournalisten Anja Ettel und Holger Zschäpitz über einen enttäuschenden Ausblick bei Bath&Body Works, die bittere Indien-Überraschung und ein attraktives Nordlicht fürs Depot. Außerdem geht es um Hewlett Packard, Bavarian Nordic, Novo Nordisk, Sanofi, Wisdomtree Cybersecurity (A2QGAH), IBM, Booz Allen Hamilton, Bechtle, Gen Digital, Trend Micro, Check Point Software, Fastly, Cloudflare, Zscaler, Fortinet, Cisco Systems, Palo Alto Networks, Microsoft, IBM, Sentinel One, Rapid7, Zscaler, Okta, Datadog, Cyberark Software, iShares Digital Security ETF (WKN: A2JMGE), Rize Cybersecurity & Data Privacy (A2PX6V), L&G Cyber Security ETF (WKN: A14WU5), und First Trust Nasdaq Cybersecurity (WKN: A2P4HV). Eure Sprachnachrichten für die 1000. Folge schickt ihr bitte an die Nummer: 0170/3753558. Wir freuen uns an Feedback über aaa@welt.de. Ab sofort gibt es noch mehr "Alles auf Aktien" bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem bei WELT: Im werktäglichen Podcast „Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

De handler tæt på all time high, flere af de store toneangivende aktieindeks, men tør man tro på, at det holder? Millionærklubben tjekker niveauerne og debatterer aktier med lytterne. Du kan høre mere om blandt andet Bavarian Nordic, Lockheed Martin og Thales. Dagens panel: Per Juul fra Juul Valueinvest og Lau Svenssen fra Svenssen & Tudborg. Vært: Bodil Johanne Gantzel.See omnystudio.com/listener for privacy information.

Synopsis: In this episode of BioTech 2050, Robert Ang, CEO of Vor Bio, shares insights on the current state of cancer therapies and next-gen modalities. He discusses Vor Bio's work on shielded stem cell transplants and CAR T-cell therapies targeting hematologic malignancies like AML and MDS. Robert also talks about his experience serving on boards and emphasizes the importance of core values in shaping organizational culture. He highlights his approach to hiring, focusing on finding individuals who are passionate about making an impact over titles. Overall, the discussion provides valuable insights into the evolving landscape of cancer treatment. Biography: Robert Ang, MBBS, MBA brings experience as a senior biotech executive and is formerly a physician, venture capitalist, and strategy consultant. Prior to Vor Bio, Robert was Chief Business Officer at Neon Therapeutics, serving as part of the early team that established the company prior to its Series A investment through IPO. Before Neon, he served as Senior Vice President of Business Development at Bavarian Nordic, where he was primarily responsible for conducting a $975 million transaction with Bristol-Myers Squibb for PROSTVAC, a Phase 3 immuno-oncology asset, and served as Head of Business Development and Medical Affairs for Cadence Pharmaceuticals. Robert also worked at Frazier Healthcare Ventures, a leading life sciences venture capital firm, where he was involved in several pharmaceutical and biotechnology investments including Cadence Pharmaceuticals (purchased by Mallinckrodt), Incline Therapeutics (purchased by The Medicines Company), Alnara Pharmaceuticals (purchased by Eli Lilly), and Collegium Pharmaceuticals. Robert also has strategy consulting experience at the Boston Consulting Group and has general surgical training. He holds an MBBS (Doctor of Medicine) from the University of Western Australia and an MBA with honors from Columbia Business School. Robert serves as the Board Chair of Enara Bio, a UK-based biotechnology company focused on non-classical HLA targets for immuno-oncology approaches. He is also a member of the Executive Committee of the Board of Directors of the Alliance for Regenerative Medicine (ARM), the leading international advocacy organization dedicated to realizing the promise of regenerative medicines and advanced therapies.

Der er flere regnskaber på banen onsdag morgen, som byder på tal fra bl.a NKT, DFDS og Bavarian Nordic. Millionærklubben tager temperaturen på nogle af udmeldingerne og taler desuden med NKT's CFO, Line Fandrup om dagens kvartalsmelding. Sidst i udsendelsen er der fokus på Apples seneste produktudmeldinger, når klubbens porteføljeforvalter Anders Bæk leverer en stemningsrapport fra tech-land, og i studiet har aktiechef Micael Friis Jørgensen fra HC Andersen Capital fingeren på onsdagens aktiepuls. Vært: Bodil Johanne Gantzel.  Producer: Kasper RiisingSee omnystudio.com/listener for privacy information.

Det er den helt store regnskabsuge for de store globale detailselskaber, men hvordan har den globale forbruger det egentlig? Bodil Johanne Gantzel spørger dagens panel Lau Svenssen fra Svenssen & Tudborg og Michelle Nørgaard fra Jyske Bank, der også tjekker dagens aktuelle regnskaber fra bl.a. Bavarian Nordic.See omnystudio.com/listener for privacy information.

Indien er det land i verden med flest indbyggere. Og en række gode vejrudsigter for økonomien har fået investorer fra nær og fjern til at samle op i landets aktier. Men er det nu en god idé at gå på indkøbstur i Indien, for det er faktisk ikke helt lige til? Det ser Millionærklubben nærmere på sammen med Thorleif Jackson, direktør i Jackson Familieinvest og Kunal Singla, direktør i COBO Consult.Millionærklubbens faste ekspert Lars Persson guider os gennem dagens marked med nyt fra blandt andre Bavarian Nordic og Novozymes. Vært: Signe TerpSee omnystudio.com/listener for privacy information.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. In recent biopharma news, Bavarian Nordic, a Dutch biotech company, has faced setbacks in its late-stage trials for respiratory syncytial virus (RSV) and COVID-19 vaccines. However, the company's CEO, Paul Chaplin, remains optimistic about the potential of the company in the travel vaccine market. Another development is that Eisai's Alzheimer's drug Leqembi has received approval in Japan and is still undergoing regulatory reviews in other countries. Intercept, a liver drug company, has agreed to a buyout by Alfasigma after failing to secure FDA approval for its research on nonalcoholic steatohepatitis (NASH). Bristol Myers' Opdivo has won a trial supporting its expanded use in lung cancer treatment, and new vaccines for respiratory syncytial virus (RSV) have the potential to be powerful tools, although their rollout poses challenges. In a merger deal worth $3 billion, HealthComp, a private equity-owned health benefits administrator, is set to merge with Virgin Pulse, a digital health and wellness company. The transaction aims to create an integrated platform for employer-sponsored health benefits, with investment firms joining forces for the merger. On the other hand, health insurer Centene is laying off 3% of its workforce due to challenges from Medicaid redeterminations and Medicare Advantage (MA) star ratings. Cano Health has sold its Texas and Nevada centers to a subsidiary of Humana for $67 million due to its worsening liquidity position. Lawmakers in Ohio have proposed minimum nurse-to-patient ratios to address nurse recruitment and retention and improve patient care. Nuance Communications has rolled out an automated clinical documentation tool called DAX Copilot, improving efficiency for healthcare providers.Roche has struck a deal to acquire preclinical RNA medicines from Ionis Pharmaceuticals, focusing on treatments for Alzheimer's and Huntington's diseases. Despite recent setbacks in phase 3 trials for respiratory syncytial virus (RSV) and COVID-19 vaccines, Bavarian Nordic CEO Paul Chaplin remains optimistic about the company's future in the travel vaccine market. ProQR's planned sale of eye drugs to Laboratoires Thea has fallen through due to certain ProQR personnel opting not to work for the French company. John Tsai has been appointed as CEO of UK heart drug startup Forcefield Therapeutics. The FDA staff have expressed "major concerns" with Brainstorm's ALS therapy. Obesity drugs like Ozempic and Wegovy could revolutionize the treatment of obesity and advance the understanding of the condition.Gilead Sciences has announced the discontinuation of a Phase III trial for its anti-CD47 antibody, magrolimab, in acute myeloid leukemia (AML). AbbVie has terminated its contract with Caribou Biosciences for the development of allogeneic CAR-T therapies. Astrazeneca and Bristol Myers Squibb have agreed to participate in the first round of price negotiations under the Medicare drug price negotiation program, despite filing lawsuits challenging the program. Italian pharma company Alfasigma has acquired Intercept Pharmaceuticals in an $800 million cash deal. Alto has reported positive Phase II data for post-traumatic stress disorder. Astellas has withdrawn its lawsuit challenging the inflation reduction act.BioNTech has announced plans to manufacture mRNA vaccines in Africa to address the vulnerability of relying on global supply chains for vaccine production. Proper chemical procurement is emphasized to avoid disruptions in the chemical supply chain for research and development (R&D) and drug manufacturing. AbbVie has terminated its contract with Caribou Biosciences as part of its strategy to cull cancer pipelines. AstraZeneca and Bristol Myers Squibb have reluctantly agreed to participate in the Medicare drug price negotiation program. Immunovant's stock has soared following positive Phase

Vacciner kom i dén grad på alles læber under coronapandemien, og derfor blev danske Bavarian Nordic smidt direkte ind i rampelyset. Siden er der sket lidt af hvert i virksomheden, og alene i den seneste måned har Bavarian Nordic skrottet et stort vaccinehåb, opjusteret sine forventninger til året - og så er der landet et dugfriskt regnskab i dag. Derfor retter Millionærklubben rampelyset mod Bavarian Nordic i denne udsendelse, hvor Rolf Sass Sørensen, chef for kommunikation og Investor Relations i Bavarian, lægger vejen forbi. I studiet er også Lars Hytting, chef for aktiehandlen i Artha Kapitalforvaltning samt Michael Fris, aktiechef i HC Andersen Capital til en snak om, hvor de ser muligheder i markedet. Vært: Signe TerpSee omnystudio.com/listener for privacy information.

Ugen byder på flere interessante regnskaber fra medicinalbranchen, og Millionærklubben benytter lejligheden til at tage et deep dive og debattere, om der er mere vækst og afkast i vente i dét segment. Dagen byder også på endnu en opjustering fra FLSmidth, og nye udfordringer for den globale finanssektor. Du kan høre mere om blandt andet Novo Nordisk, Bavarian Nordic, Ascelia Pharma Hør, hvad panelet, teknisk analytiker Lars Persson og senior aktiestrateg Michelle Nørgaard, mener om sagerne, når Bodil Johanne Gantzel byder indenfor til finansdebat. See omnystudio.com/listener for privacy information.

Efter et par negative børsdage tyder noget på, at vinden igen er ved at vende. Millionærklubben ser på sagen, dykker ned i dagens regnskabstal fra A. P. Møller - Mærsk og svarer på spørgsmål fra lytterne. Du kan høre mere om blandt andre Bavarian Nordic, Betsson, NKT, Brdr. Hartmann, Lundbeck, Bravida, Concordia Maritime, Norwegian, DNO, Aker BP, Vår Energi og Okea og ISS I studiet: Lau Svenssen, Lars Persson og Bodil Johanne Gantzel. See omnystudio.com/listener for privacy information.

Et ord bliver centrum i dagens udsendelsen: Aktieinspiration. Millionærklubben får nemlig besøg af Thorleif Jackson, direktør i Jackson Familieinvest, og Per Juul, direktør i Juul Value Invest, som hver især har taget en håndfuld aktier med, som de finder interessante. Lars Persson, Millionærklubbens faste forvalter, guider os gennem dagens marked.Vært: Signe Terp Du kan i dagens afsnit blandt andet høre om aktierne: Apple, Alphabet, TAG Immobilien, Leg Immobilien, PayPal, Cigna, Pandora, Deutsche Wohnen, Balder, Walgreens Boots Alliance, NKT, Bavarian Nordic, Novo Nordisk og Vonovia.See omnystudio.com/listener for privacy information.

Friske regnskabstal fra bl.a. allergikoncernen ALK og biotekselskabet Bavarian Nordic. Bodil Johanne Gantzel ser på sagerne sammen med Lars Persson i studiet, der også tegner billedet af et svensk ejendomsselskab, som hænger i med det absolut yderste af neglene. På telefonen kommenteres regnskabstallene af fra ALKs CEO, Carsten Hellmann og Sydbanks senior analytiker, Søren Løntoft Hansen om Bavarian Nordic.See omnystudio.com/listener for privacy information.

Traditionen tro er Tryg først klar med 1. kvartalsregnskab. Millionærklubben tjekker ind hos den afgående administrerende direktør, Morten Hübbe, for en kommentar til årets start. I studiet ser Jyske Banks senior aktiestrateg, Michelle Nørgaard, og Nordnets investeringsøkonom Per Hansen på gårdsdagens regnskab fra Tesla og varmer desuden op til de kommende ugers travle danske regnskabssæson. Foruden Tesla og Tryg kan du også høre om Novo Nordisk, Zealand Pharma, Mærsk, Vestas, Bavarian Nordic og Eli Lilly Vært: Bodil Johanne Gantzel. See omnystudio.com/listener for privacy information.

Regnskabssæsonen står for døren, og vi har allerede fået de første opjusteringer fra blandt andre en række banker og Novo Nordisk. Samtidigt er der igen god stemning på aktiemarkedet, med flotte stigninger i både USA og Europa. Klubbens egne forvaltere Lars Persson og Lau Svenssen er i studiet for at vende de seneste tendenser og tage imod spørgsmål fra lytterne. Du kan høre mere om blandt andet medicinalselskabet Novo Nordisk, bilproducenten Volvo, Danske Bank, flyselskabet SAS, høreapparatkoncernen GN Store Nord, fragtselskabet DSV og industriselskaberne Lundin Mining og FLSmidth og allergimedicinproducenten ALK samt Trelleborg. Du kan også høre om vaccineproducenten Bavarian Nordic, kabelproducenten NKT samt rederiet Mærsk og  Ericsson. Vært: Sara SjølinSee omnystudio.com/listener for privacy information.

Insulin, høreapparater og langsigtede investeringer.Det er bare nogle af de ting, som Millionærklubbens Lau Svenssen og direktør i Jackson Familieinvest, Thorleif Jackson, vender i dette afsnit.Det skal nemlig handle om GN Store Nord, Novo Nordisk og ikke mindst, hvordan man udvælger langsigtede investeringer.Lars Hytting, aktiechef i Artha Kapitalforvaltning, er også med over telefon. Vært: Signe Terp. Du kan i dagens afsnit også høre om aktierne: Simcorp, Netcompany, ALK og Bavarian Nordic.See omnystudio.com/listener for privacy information.

US equity futures are indicating a lower open as of 05:00 ET. European equity markets are mostly firmer, following broad weakness in Asia, where markets were in risk-off mode following US CPI data, with the Hang Seng leading losses in the region. The early macro focus in Europe is on UK inflation data, with headline inflation softer than expected in January. The US economic calendar is in focus again today with retail sales the highlight.Companies Mentioned: Emergent BioSolutions, Bavarian Nordic, Ford Motor, CATL

In this episode, host Shikha Jain, MD, speaks with Christopher Heery, MD, of Arcellx, Inc. about making the transition from physician to chief medical officer, providing more access and education for clinical trials and more. Welcome to another exciting episode of Oncology Overdrive :14 About Heery :25 The interview 3:06 Tell us a little bit about your journey. How did you get to where you are today? 3:21 Do you have any advice for those who are interested in making the transition into roles like CMO? How would you guide somebody who is interested in doing that? 7:29 Jain and Heery on the transition in many physicians from patient care to health care leaders and retaining people in clinical medicine 10:41 Jain and Heery on the disconnect in understanding health care costs 13:42 About Arcellx, Inc. and what is coming down the pipeline 15:34 Jain and Heery on how far cancer care has evolved, and the challenge of making this care more accessible to underserved communities 21:30 Jain and Heery on the challenge misinformation creating fear and educating about treatment, clinical trials and immunotherapy 27:23 Jain and Heery on the growing mistrust in the health care system and its effects on the doctor-patient relationship 34:52 If someone could only listen to the last minute or two of this episode, what would you want them to take away? 42:11 How to contact Heery 43:18 Thanks for listening 43:56 Christopher Heery, MD, has been the chief medical officer of Arcellx, Inc. since April 2021. Prior to that, he served as chief medical officer at Precision BioSciences and Bavarian Nordic. Heery is board-certified in medical oncology and internal medicine.   We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Heery can be reached on Twitter @ChrisHeery.

Episode Notes Episode Summary For this This Month in the Apocalypse episode Brooke, Margaret, and Casandra all researched different topics and discuss them. Margaret talks about climate collapse, droughts, floods, wildfires, the cost of wheat, and the dangers of rising humidity for wet bulb temperatures. Casandra talks about Monkey Pox, rises in other viral and vector borne illness, and discovers why rain might actually be a bad thing for your food. Brooke talks about student loan forgiveness and things you, brave listener, might not be aware you are forgiven for. Everyone attempts to get us sponsored by 'Big' Rain Barrel. If you're out there 'Big' Rain Barrel. Please sponsor us. Host Info Casandra can be found on Twitter @hey_casandra or Instagram @House.Of.Hands. Margaret can be found on twitter @magpiekilljoy or instagram at @margaretkilljoy. Brooke is just great and can be found at Strangers helping up keep our finances intact and on Twitter @ogemakweBrooke Publisher Info This show is published by Strangers in A Tangled Wilderness. We can be found at www.tangledwilderness.org, or on Twitter @TangledWild and Instagram @Tangled_Wilderness. You can support the show on Patreon at www.patreon.com/strangersinatangledwilderness. Next Episode Come out Friday, September 23rd, and every two weeks there after. Might be about thru-hiking, Parenting, or Archiving. Transript An easier to read version is available on our website TangledWilderness.org. Margaret 00:16 Hello, and welcome to Live Like The World Is Dying, your podcasts for what feels like the end times. I'm one of your hosts, Margaret killjoy. I have Brooke and Casandra with me as well as cohosts today, because today, you will be very excited to know that the world's still ending...that we are doing our second monthly This Month in the Apocalypse and we're going to be talking about basically the last month and the I guess that's in the name. Okay. So, Brooke, Casandra, do you want to introduce yourselves? Possibly with Brooke going first. Casandra 00:52 Your name was first. Brooke 00:53 Yeah. Okay, alphabetically. Hi, everybody, it's Brooke Jackson again, coming to you live? Oh, wait, no, this will be recorded by the time you hear it. From the sunny lands of the Willamette Valley in Oregon. Casandra Johns 01:11 We're all in the Willamette Valley right now. Margaret 01:14 It's true. Casandra 01:15 It's true. This is Casandra. That's me. Margaret 01:19 Okay, and so this will be a very short episode, because actually, nothing bad has happened in the world, certainly not nything that feels end times ish, nothing out of the ordinary. I'm under the impression we have reversed most of the major...I mean, I think Biden passed a bill. So, I'm pretty sure climate change is over. And COVID is over. I learned that just the other day walking into a place where I thought everyone would be wearing masks, but it's over. So that's cool. Or, alternatively, let's talk about how China's in the worst heatwave in human history...in recorded history. We're gonna cut it up into segments. And I'm gonna go first with my segment. Casandra Johns 02:06 Do we need to say "Du duh duh duhh, Channel Zero? As part of the intro? Brooke 02:13 Do a Jingle? Margaret 02:16 Yes. Okay. You want to do it? Brooke 02:20 She just did. Casandra 02:21 Oh, yeah, I did. Duh duh duh duh! Margaret 03:19 Okay, and we're back. Okay, so, China...70 Day heatwave as of several days ago, now. And by the time you all are hearing this, I believe we're recording this about five days before this episode comes out. So, who knows what will have happened? There has been a lot of heat waves and floods all over the world this summer. And so China's in the middle of a 70 day heatwave. The drought has reduced hydroelectric output, which huge areas were reliant on the electricity because the water levels are so far down. And of course the electricity is what powers the AC. So no air conditioning is really fun as things get really hot. AC has been turned off in a lot of office buildings. It's cut power to tons of industry, including a bunch of car manufacturers where I'm a little bit like "Eh, whatever. Cars are bad." I mean, I drive cars so I'm kind of an asshole and hypocrite. Anyway. But also solar panel output and EV battery plants and like lots of stuff that's like being pitched as the alternative to things...y'all can feel free to cut me off too as I talk about these things. I'm just like going through my notes. And I don't know, it's breaking records all over the place by like four degrees in a lot of places. It's four degrees Fahrenheit. Brooke 04:44 What is heatwave in this context? Like are they having like, you know, 115 degree temperatures, are they just? Margaret 04:53 I mean, so. I mean, I believe in localized places. It's getting like crazy hot but what's interesting about this is that it's it's more the length of it and the abnormality to its usual that is, like, it's a lot of this stuff is like 106 degrees Fahrenheit and things like that. You know, things that are very not nice, but are...well, human survivable. Although we should probably at some point talk about wet bulb temperatures and how dry places are survivable at substantially higher temperatures than humid places. But yeah, so it's it's, it's an it's an abnormality causing problems as far as I understand, rather than like, just specifically, if you step outside, you will be scorched by the heatray that is the sun. It's affecting over a billion people, which is a lot of people. The area of the heatwave is 530,000 square miles, which for context is Texas, Colorado and California combined. Casandra Johns 05:57 Does that overlap with the area...like, isn't there like a massive wildfire happening in China right now? Margaret 06:04 I think you know, more about the wildfires than I do. Casandra Johns 06:07 I don't know what region it was in. Margaret 06:09 Okay. Casandra 06:09 I guess I'm curious. Of course, they're related because everything climate-y is related, ultimately. Margaret 06:16 Yeah. Casandra 06:19 Yeah, I'm curious how closely they're tied together. But, if you don't know, and I don't know, that's fine. Because there's also a massive wildfire. And that sucks. Margaret 06:27 Yeah. There's a massive wildfire. Brooke 06:31 Is that a continuous area, Margaret? That five? Whatever, something miles? Margaret 06:37 You all are exceeding my level of research that I did, because I did research about the entire world. So I don't know. Brooke 06:44 Okay, fair. Casandra 06:45 Oh, yeah. You have more. This is just like heat waves everywhere. Okay. Margaret 06:48 Yeah. Okay. And also joining us today on playing the squeaky toy in the background is Rintrah, the best dog in the world. Brooke 06:59 Can confirm. Margaret 07:00 The best dog in the world. No complaints? Okay. Yeah, I, you know, there's a lot more I don't know about this, right? But this was one that I haven't even seen really cropping up much in the media at all. And actually, one of the things that's sort of interesting and terrible and telling is that a lot of the information that I've been able to find about climate change disasters comes from the business media, like, a lot of this is about how it will affect stock prices, how it will affect, you know...300 Mines are shut down right now in China, or as of you know, two days ago when I did most of the research for this recording. And so it talks more about the 300 mines that have been shut down instead of the 119,000 people who have been evacuated from their homes. And it's just, it's a real problem. There's a lot of photos of like, low reservoirs that are like 20 meters below what they're supposed to be and things like that. And, of course, to tie everything into everything else, you know, things that happen in one place don't only effect that region. The drought is fucking up their harvest, and fertilizer for export has been affected, which will probably fuck up the world's food supply, which was otherwise very stable. So, I don't think that's gonna be a problem. Casandra Johns 08:16 The world's been chaos, but at least we know, food is cheap and available. Margaret 08:20 And will stay that way. Margaret 08:22 Okay, so then the one that I'm finally starting to see more get talked about in the media, thankfully, although it's annoying, because it's only been talked about because now there's like dramatic photos. But whatever. I mean, I'm not blaming people for not paying attention to everything that's happening in the world. Pakistan is having flooding, like just absolutely massive flooding. I've read reports saying that there's a half a million people living in refugee camps. It's taken at least 1000 lives, it's fucking up food production. Over a million homes have been destroyed. A third of the country is underwater. Have y'all seen the satellite image photos? Casandra 08:22 Yep Casandra Johns 08:59 Yeah, and they're referring to it as a 'lake.' Which makes me wonder like, are they anticipating at least some portion of it to remain? Like, "And look at our new lake!" Margaret 09:10 Yeah. Casandra 09:12 I heard I heard someone else I heard someone referred to it as a 'small ocean.' Margaret 09:18 Yeah. Margaret 09:19 Yeah. And, and Pakistan is the the fifth most populous country in the world after China, India, U.S., Indonesia, I think. Yeah. And so it's like, it's a big fucking deal and a big fucking problem. And one of the other problems because capitalism solves...makes everything worse. Pakistan has taken out a $1.1 billion dollar loan from the IMF, which for anyone following at home, the IMF is a predatory lending organization called the International Monetary Fund, that actually a lot of modern leftist politics, at least in the Western world and actually a lot of the developing world kind of cut its teeth in the...during the, the turn of the millennium fighting against the IMF and the World Bank, specifically because of the stuff that they do, which is that they loan predatory. It's like a payday loan. You know, it's like a paycheck loan place, but for entire countries, they loan you $1.1 billion, and then you're going to be paying off the interest for the rest of your life as a country. And of course, a lot of what's happening right now is that developing nations as they take out these loans are therefore forced to extract more fossil fuels from their own countries, in order to pay off the interest of their loan, not even touching the principal, trapping us further and further in the cycle of what's destroying everything. So that's all really fun. Okay, then, East Africa, particularly Kenya, Somalia, and Ethiopia, are also facing prolonged drought, rising food prices. A lot of this is because of Russia's invasion of Ukraine. This is projected to leave 20 million people hungry with an estimated 3 million potential deaths if aid isn't delivered, and these three countries represent 2% of the world's population, but 70% of the extreme food insecurity. And most of...about 90% of the wheat imported by East Africa comes from Russia and Ukraine, which are of course, having some issues right now. They're not famously friends. But you're thinking to yourself, "Well, I'm a wheat farmer in the US, and the high prices are good for me." They are not. Things are not good with domestic wheat production here in the United States, either, which, of course, affects large quantities of the world. Also, the US is a major grain exporter. And so this is things that affect the US do affect everyone else. And not just because we're the center of Empire. Drought is affecting wheat fields in Kansas, Oklahoma, and Nebraska. Kansas is estimating a 30% drop in their harvest. Oklahoma is estimating a 50% drop, in its harvest. And so even though you have these, like record high prices for wheat, farmers are expecting to lose money, because they're not able to grow enough. You look like you have a question. Brooke 09:19 Oh wow. Casandra Johns 12:24 And yeah, so we talked about this a little bit the other day, I think, like I'm not sure if people realize what it means when the wheat crop is devastated. You know, it's not just like, "Maybe I can't eat bread." Brooke 12:43 There's more to it than that? Casandra Johns 12:45 Right! I mean, the next thing I think of is like, who eats the wheat? Not just humans. You know, like, I can't eat wheat, but like, I eat beef. Margaret 12:58 Yeah. Casandra 12:58 And chicken. Margaret 13:00 Yeah. Brooke 13:00 Was does that matter, Casandra? Casandra 13:03 Maybe they eat wheat. Just the like domino effect. Margaret 13:07 Yeah. Casandra 13:08 Yeah. When we talk about rising food prices and rising fuel prices, and how those are connected to like rising everything prices. Margaret 13:15 Yeah. And book prices most famously. Brooke 13:16 Okay, well, like, I have a solution. Casandra 13:19 Okay, what's your solution? Is it Communism? Brooke 13:19 Cause, we're all about solutions here. Well, you started talking about Pakistan being all flooded like the country's a giant lake. And then you said drought in the US and I'm like, "Let's just pick up some water over there and just put it over here." And then there won't be a drought or flood. Margaret 13:36 So what's so great and I'm gonna get to in a moment is that drought and flood are entirely related. I think you knew this, and we're just setting me up to say this, but they're absolutely related. The more drought you have, the worse flooding you have, which of course, like boggles my immediate science, right? My non science brain is like, "But water is the opposite of drought," you know, and we're gonna get to them second. Okay, so also in the US, Lake Mead is drying up. It's the largest reservoir in the United States, it provides water to 25 million people. It's possible that soon it won't have enough water to feed the Hoover Dam, which provides electricity to about a million people. And the one upside of all of this drought..this is really selfish. It's kind of like interesting the stuff they keep finding in the water. They keep find... Margaret 14:26 Yeah. They're like finding like some guys like "Oh, look a barrel," and he like pops open some barrel from the 1920s. And just like a dead guy with a bullet in his skull, and they're like, "Oh, the mafia really did just drop people off in barrels," which led me to the conclusion that apparently leaving dead bodies in large body in large bodies of water is more effective of a strategy than I've been led to believe. Casandra 14:27 Well, they haven't they also...hasn't also revealed like Nazi...like sunken Nazi ships and shit. And then they're like the.... Casandra 14:27 Crime? Margaret 15:01 Yeah, not in Lake Mead, though. Casandra Johns 15:04 Right. But then..No, but I'm just saying like everywhere it's revealing interesting things like in Europe the...what are the stones called? Margaret 15:12 The Hunger Stones. Casandra 15:13 Hunger Stones? Margaret 15:15 Yeah. Casandra 15:15 So apparently, what's the context for this? Previously, in history when there were massive droughts and like rivers dwindled down to nothing, people made carvings in the stones at particular water levels with these like really epic, maybe Margaret's looking at some examples, of these really epic miserable statements about like, "Fear ye, fear ye, if the water gets this low..." Margaret 15:40 You're dead. Casandra 15:40 Yeah, but people are seeing those now, which is terrifying and interesting. Margaret 15:47 Yeah. Terrified and interesting is a good way to describe the current epoch. Brooke 15:52 Cool. That's the silverling, the mud caked lining. Brooke 15:52 Yeah. There was. It's not happening right at this moment. But here locally, when the Detroit reservoir got real low a couple of years ago, there was a town that had been flooded when they built the dam there and it was low enough that like, remnants of this town were visible, including like an old wagon, like covered wagon base kind of wagon and other cool artifacts. Brooke 16:27 See some history before we all die. Margaret 16:30 Yeah, yeah, exactly. Brooke 16:31 Great. Margaret 16:32 So, in California, heat and drought are also combining as power usages reaches a five year high power use, because people are running more and more air conditions. I didn't quite realize exactly how...I don't I don't have a percentage in front of me...But like, air conditioning is a really, really big use of electricity. And so in California, the grid is estimated...is expected to become unstable, although that might have already happened. It was supposed to happen like this week. So that might happen by the time y'all hear this. Or maybe it didn't happen. And I'm here I am chicken littling, all day long. And, of course, Jackson, Mississippi flooding. The capital of Mississippi, which is primarily black city has left 150,000 people without drinking water. Sooo... Brooke 17:18 I haven't heard about this at all? Margaret 17:20 Oh, yeah. And there's some mutual aid groups on the ground. Cooperation. Jackson is a long standing organization that works to sort of build dual power and do all kinds of awesome stuff in terms of cooperative economics and things like that. And they are doing a lot of mutual aid work. I believe there's also a group and maybe this is actually not maybe they're not directly related. I'm not sure there's a group called Hillbillies Helping Hillbillies that I've at least seen talk a lot about this issue. I don't know if they do most of their work down there or if they've been more focused on the Tennessee floods. Casandra Johns 17:54 I know Mutual Aid Disaster Relief is also doing work there. Margaret 17:59 Yeah. So "Why does all this stuff happen, Margaret?" you might ask. Brooke 18:07 Why does all this stuff happen, Margaret? Margaret 18:09 Well, I am an expert named Jennifer Francis, a senior scientist at the Woodward Climate Research Center in Falmouth, Massachusetts, and my quote, that is definitely me is, "As the air and oceans warm under a thicker blanket of greenhouse gases, more water vapor evaporates into the air providing more moisture to fuel thunderstorms, hurricanes, nor'easters and monsoons." Basically, as the temperature rise of the Earth, the warmer atmosphere can hold more water vapor, every degree of...every increase of one degree Celsius can boost the capacity for holding water vapor by about 7%. So that's fun. And also as things get more humid, you're like, "Okay, well, that's cool. It's like more tropical and stuff, right?" Higher humidity is substantially more dangerous, like heat and humidity is what kills people, because of the way that our bodies thermo regulate basically, like, if you're at 100% humidity, and the temperature goes above your body temperature, you die. Not like instantly, right? But your body loses its ability to thermo regulate. And so that is the wet bulb temperature is the temperature at 100% humidity, and that can be calculated out from there. So, for example, 105 degrees Fahrenheit at 5%. humidity is not that bad. It's like 61 degrees wet bulb, right? You're not in danger, I mean, you can be in danger zone from other parts of it, you need to get in shade, right? But like, whereas 105 degrees at 95% humidity is 103 degrees wet bulb. So, and for context, you know, it's like I used to never really think about the level of humidity that I lived in until I moved to the South and I had to worry about mold and all kinds of other shit. But, much of the South, and San Francisco and also I believe much of Alaska sit at around 80 to 90% humidity, whereas the Southwest might be at around 30% humidity. So, when you hear about temperatures at different levels in different parts of the country, the humidity that they're facing, like matters in terms of how catastrophic this type of thing is likely to be. And then the "What to do about it section!" Don't worry, we're almost done with the terrible climate shit part. Casandra Johns 20:20 I feel like earlier, you mentioned something about the relationship between flooding and drought. I was hoping you were gonna circle back to that. Margaret 20:28 Okay. Oh, yeah. So. So basically, the...some atmosphere shit I only half understand. But, as everything gets hotter, more of the air like sits...and more of the water sits in the air and that...it just fucks everything up. So, like, the rain falls off fucked up. I, I kind of like, wrap my head around it. And then I, it unraveled, you ever, like study things that are completely outside your thing? And then you like, you get your takeaway, and then the details like dissolve? That's what happened to me while I was researching this? Casandra Johns 21:00 No, that's I didn't realize it had I, I thought my assumption was it was going to be that, you know, you can look up videos of this where like, people put a cup of water upside down on like dry soil, you know, partially damp soil and like saturated wet soil. And the cup of water immediately, like seeps into the ground in the saturated soil, but it takes a really long time for the dry soil to absorb the water. Margaret 21:25 Yeah. Casandra 21:25 And so my assumption was like, "Oh, if there's a drought and the soil is bone dry, it can't absorb moisture very effectively." Margaret 21:33 Yeah. Casandra 21:33 Which is counterintuitive, maybe? But...then it floods. Margaret 21:36 I think that is a big part of it. Yeah. Casandra 21:38 Okay. Margaret 21:39 And then also, I was even just like...go ahead. Brooke 21:43 I was thinking about how matter can't be created or destroyed. And so the water still exist somewhere, even though it got sucked up from the dry places. And that might be why it ended up flooding in other places because the water still exists. Margaret 21:58 Well, a lot of places it's literally the same place will have droughts and floods. I think Texas was dealing with that I think it was Dallas, was having a record drought and might still be in a record drought and then had like, really fuck off flooding. I think it was about a week or two ago. That was like destroying everything. And, you know, because if the rain patterns are just completely different than Yeah, what the ground is used to absorbing and like, and which ties into what to do about it. A lot of what to do about it needs to happen at the scale that we're not necessarily going to talk about right now. But, rainwater catchment and drought areas is super important. And, you know, I was looking it up because there's this like. I'd always been sort of told that rainwater catchment like fucks up the water system of that area, you know, because Colorado has, they have re-legalized it a little bit in 2016. But it's been illegal for a very long time to catch rainwater in Colorado because they're like, "Oh, it's so dry here. We need all the groundwater." That was what I had always got told. The real reason's that Colorado made rainwater catchment illegal have a lot more to do with...capitalism, and the way that water rights are, you're basically stealing from people in entirely different areas if you catch the rainwater at the source or whatever. And, it it can affect things,right, if you like take water that could otherwise have ended up groundwater, but you're mostly it's mostly like shit that would have run off anyway. And so rainwater catchment increasingly in a lot of places, I believe Arizona has like new laws that like require new buildings to include rainwater catchment. There's entire countries who I didn't write down the names of that require rainwater catchment in all new buildings, especially island nations, I'm under the impression and so rainwater catchment is cool. And then, Arizona you can get rebates if you install rainwater catchment. In Colorado, it is now legal again for like home level and there's like all these like rules and shit. And you're, you're only allowed to store two barrels for a total of 110 gallons and you can only do it at like, home, or whatever. I'm sure there's ways that people could imagine catching rain water without getting caught. The CDC points out that rainwater is generally not safe to drink without treatment. You can use it to water non food plants without treatment. I say this, I showered with rainwater for the past three years and don't give a shit. But, maybe I shouldn't recommend that to other people. But, also filtering rainwater is like not the biggest deal in the world. And then... Casandra Johns 24:39 Also like, the idea of only using it on non food plants is really funny to me, because like it just rains on my plants, you know? And then I eat them. Margaret 24:51 Yeah. Brooke 24:52 You shouldn't let rain land of your plants. Margaret 24:54 You shouldn't be eating food from plants. Plants comes from stores, Casandra. Casandra Johns 24:59 Uh oh. Okay. And if they get rained on specifically then they're like poison. Margaret 25:06 Yeah, me, okay. Like, you walk out of a food store, the main place that people get food, like McDonald's, and you have your chicken nuggets, or... Casandra 25:14 And then they get rained on? Margaret 25:16 You wouldn't want to eat them now, would you? Casandra 25:18 Okay, I see what you mean. Margaret 25:20 Yeah, no, I like that part about the like non food plants or whatever is like to me is like that's what the CDC says. The CDC has lost a lot of...I don't trust it as much as I might have used to. Casandra 25:36 Interesting segue to... Margaret 25:39 Yeah. Well, there is one more part though that I believe one have you added to the notes about soil remediation and dry gardening? I'm wondering if you want to talk about some of that. Brooke 25:52 That has to be Casandra, cause it wasn't me. Casandra Johns 25:54 Oh, I mean, that was me thinking about like, how the what I was saying before how bone dry soil...the best place to store water is in the soil. Right? Margaret 26:04 Yeah. Casandra 26:06 Just like the best place to store nitrogen is in the soil. But, you know, if I lived in a super dry area, and this is only so effective for like the home gardener, this like ideally would happen on a large scale. But, if I lived in a really dry area, I'd be working really hard to like improve my soil health so that it can store more water. So that things like dry gardening are possible. So I can you know, have food even in a drought. Margaret 26:32 What is dry gardening? Casandra Johns 26:36 Dry gardening is gardening with little to no, like, manually added water. Margaret 26:43 Is that where you like mulch the shit out of it all to prevent evaporation? Casandra Johns 26:46 Yeah, you can do it that way. You can also...there. There's a...well, it's on my bookshelf, so I'm not gonna mention it because I can't remember the title right now. But yeah, mulching, spacing your plants a lot farther out, making sure that your soil can store water so that if you know we live, where I live, it rains a lot in the spring. And if the plants I plant have a room, and the soil is fluffy enough that they can send the roots really deep, then in the summer, when it's dry, they can still access the water that's stored in the soil. Does that make sense? Margaret 27:19 Cool, and then they grow chicken nuggets? Casandra 27:22 Yep. Margaret 27:23 Cool. Okay, so back to the clever segue that I broke about not trusting the CDC.... Casandra Johns 27:36 Yeah, yeah, I Okay. So, we realized we should probably say at least something about monkey pox. Because it's the thing that exists. My notes are titled monkey pox sucks. And... Brooke 27:52 Correct. Casandra Johns 27:53 Correct. Yeah. And I realized in researching this that I knew very little, I think I was just like, "We live in a time where there will be epidemic after epidemic," and I'm, you know, mentally overloaded on this topic. And had a lot of assumptions that were wrong. But, one interesting thing I found out is that the CDC is saying it's not transmitted....It's not airborne. Which, you know, they've kind of gone back and forth about whether masks are going to help...masks. I can't enunciate....whether masks are going to help prevent the spread. Brooke 28:37 If the mask prevents you from licking someone's open wounds, then then I say that would be helpful. Put your mask on. Casandra Johns 28:44 But, then there's there are other recommendations around like, avoiding close face to face contact with people. So that's all. I think I'm just affirming that I am also skeptical of CDC guidelines at this point, which is a bummer. Margaret 28:59 Yeah. Casandra 29:01 Anyway, do you want to hear all about monkeypox? Margaret 29:04 Yeah. Yay. Casandra 29:06 Yay. Margaret 29:06 What a fun show we make. Brooke 29:10 That's like a game, right? It's a children's game that you play. It's fun. Spread all over? Isn't it great? Casandra 29:18 No. Margaret 29:19 It's one of those games with a 1-3% death.... Okay, please continue. Brooke 29:24 That's pretty low. It's fine. Casandra Johns 29:26 Oh, my God, what a world that we live in. So apparently was discovered in 1958 in laboratory monkeys. So, you know, you can insert something here about blaming capitalism for everything. Because maybe it wouldn't have been a thing if monkeys were not in laboratories? Anyway, it's a cousin of smallpox in the first human case was recorded in 1970. When I first heard about monkey pox in May or whatever I was like, "Oh, cool and new disease." It's not new. It's been around for decades. So, it's really interesting that like, we don't have a vaccine that can quickly be rolled out. Do you want to guess why that is? Margaret 30:14 Is it Capitalsim? Brooke 30:14 I guess 'racism.' Casandra 30:15 Racism. Brooke wins with 'racism.' Brooke 30:23 Yay? Casandra 30:26 Yeah, so it was that to be uncommon in humans, but cases started increasing around 1980. And most of the cases have been documented in central and western Africa. That correct? In Africa. Margaret 30:41 Yeah, you said Nigeria is like one of the main spots of it? Casandra 30:45 For this outbreak. Margaret 30:46 Okay. Casandra 30:48 Yeah. So, and they think that one of the reasons....so there have been multiple outbreaks since it was first recorded in humans in 1970, which I didn't realize, because we don't hear about them, because mostly they've taken place in Africa. Which is just depressing. And I'll come back around to that in a minute. But, they think that that the increase in cases might be connected to the fact that it is related to smallpox. The smallpox vaccine, they think gives like, 85% that it is like, 85% effective against monkey pox. But most people don't get the smallpox vaccine anymore. Brooke 31:27 Yeah. Casandra 31:28 And I think that's related to the increase in monkey pox cases. Margaret 31:33 People don't get the smallpox vaccine anymore, because smallpox kind of went away because of vaccines? Casandra 31:40 Yeah, Brooke 31:41 No, it just stop being trendy. People were like, "That is not cool anymore. I'm not gonna take that one." Casandra Johns 31:48 Yeah, yeah. Which then is like, there's a whole tangent in here about who and how they decide a disease has been 'eradicated.' I'm doing air quotes that you can't see has been, 'eradicated.' Especially when something like monkey pox is trance was initially transmitted from animals to humans. And so, yeah, I don't know, is smallpox eradicated? I don't know. I'm not an epidemiologist. But I'm curious. So, let's see. Okay, so the current outbreak grew from one case in Massachusetts in the US, I'm talking about the US now, May 17. And at this point, you know, however many days it's been since May, there are almost 20,000 cases in the US, which is a lot of cases. Brooke 32:40 I mean, it sounds like a big number. But, also I know, there's a lot of people in the US, but also, I don't know how much cases of other things that we know about are common. So I don't have any frame of reference. Margaret 32:51 Yeah same. Casandra 32:53 Yeah. Brooke 32:54 Well, it's way smaller than Covid. Casandra Johns 32:57 Right. It is way smaller than Covid. But, you know, and it's, it's sort of like Covid, you're probably not going to die from it. But then there's the asterisk, 'unless you're immunocompromised already,' you know. So like, who are we? Who are we willing to throw under the bus for this? Brooke 33:13 So just Casandra. Casandra 33:13 Yeah, just me. Yeah. But then there's also public health experts are apparently warning that the virus is on the verge of becoming permanently entrenched here. Margaret 33:24 Cool. Casandra 33:25 So maybe 20,000 isn't, you know, a big chunk of the population, but in terms of like, a virus, it's bad news, because we don't really want it to become entrenched here, right? Brooke 33:38 Yeah, viruses, bad. Casandra 33:41 Virus equals bad. Okay. Okay, so, so there's been a lot of criticism about Biden's administration and their sluggish response to the outbreak. I read a really interesting report. I think WaPo [Washington Post] was the first place to report on this, but they said that, on August 4, US Health and Human Services officials plan to stretch the country's limited supply, or they announced, that they plan to stretch the country's limited supply of vaccines by splitting doses to cover five times as many people. This is after saying that they had plenty of doses. So, already sketchy. Yeah, cool, cool. And then the chief executive of Bavarian Nordic who's the vaccine manufacturer responded by accusing the Biden admin of breaching contract by planning to use them in this like inappropriate way by splitting the doses and then apparently threatened to cancel all future vaccine orders so that....Yeah, I'm not sure how that was resolved. Brooke 34:45 Capitalism. The other 'ism' now at play. Margaret 34:50 I was right. I was late. Casandra Johns 34:57 So the big concern for me in researching this was how it spreads, because I have a child who's about to go back to public school, so apparently animal to human transmission, it's spread by direct contact with blood, bodily fluids or cutaneous or mucosal lesions of infected animals. And then human to human transmission is close contact with respiratory secretions, which to me says airborne, right, right? Is that not what that means? Anyway, respiratory secretions, skin lesions of an infected person, or recently contaminated objects. So things like bedding, clothing, stuff like that. Um, but the CDC says it's not airborne. So, take that, as you will. I don't know. How are you gonna take that, Brooke? Brooke 35:41 Right. Well, I mean, respiratory secretions that does sound more significant than just like, you know, air droplets, like we talked about with covid, like, more moist, kind of things coming out of you, like sneezes and coughs and stuff that actually sprays more liquid matter? Casandra 36:07 So, use your imagination with that. Margaret 36:08 We could just go through and describe every act that could... Casandra 36:10 Don't spit in people's mouths. Brooke 36:14 Damn it, there goes half of my kink play. Margaret 36:18 I mean, it does seem like it's less contagious than like, because like, okay, right, like, because they said originally COVID wasn't airborne. And they weren't always wrong about that, right? But, the fact that it's been here for months, and is at 20,000 cases, is like, 'promising,' in that it seems less contagious than COVID? But that's, I guess I'm talking about like, the first or second most contagious virus that the world's ever faced. So, I guess it's a terrible benchmark to compare it to. Casandra Johns 36:49 Yeah, I think comparing everything to covid is probably not in our best interest, especially because a lot more people are comparing this to AIDS, in terms of the communities it's impacting, and how it's spreading. So it's, it's okay, let me go back to my list. Alright, so the incubation period is usually six to thirteen days, it's thought to be mainly spread through sexual activity, specifically, men who have sex with men and have multiple partners, though now they've sort of expanded that to include like queer and trans people, which is good. Not that it's spreading in queer and trans communities, but that they're changing language. So then I was like, "Well, is it an STI, right?" And I Googled "Is Monkey pox and STI? And the first two articles that came up, were: Number one, "Monkey pox is an STI and knowing that can help." And then number two is, "Monkey pox is spreading through sex, but it's not an STI." So you know, I'm not a doctor. Casandra Johns 37:02 It's not an STI. Casandra 37:29 Okay. Brooke 37:31 Because it's not it's, yeah, go ahead. Casandra Johns 37:52 But it seems to mainly be spreading through sex, probably because of the close contact involved. Margaret 38:02 Yeah, I mean, like, like, scabies is... Brooke 38:04 Yeah, like not through the sex itself. Casandra 38:06 Right. Brooke 38:07 But through the close physical contact of you know, that happens during sex. Casandra Johns 38:12 I think. I also saw a list. I think it's LA County. I was reading their like, list of eligibility criteria, and maybe risky behavior to avoid...'in void.' Would that even? Yeah, thank you. I was just trying to figure out what my made up word means. Risky behavior to avoid and they listed that, like, we're still learning about how it's transmitted, right, which is wild for a disease that's been around since the 70s. But, they listed that it could possibly be transmitted through semen. Like not solely but that could be another way that it's transmitted. Brooke 38:53 Sure, transmitted through bodily fluids, but the distinction when it when it's an STI is something that's sort of limited to being transmissible through kind of the genital region. Casandra Johns 39:10 Is that why one type of herpes is considered an STI, and the other isn't? Brooke 39:14 Yeah, so you can like can get both of them in both places because of oral sex. Casandra 39:21 Huh, that's interesting. Brooke 39:23 But yeah, technically. That's why. Casandra Johns 39:25 Thanks for knowing more about STI classification than me. I appreciate it. Brooke 39:29 Well, I fuck a lot. So I got to know these kinds of things. Casandra 39:35 All right, moving on with my notes. My next... Brooke 39:40 I just made everyone turn a scarlet blushing red color because I have non prude among this collective. Casandra Johns 39:48 I'm not blushing. I'm not prudish. I'm just Demi. Okay, so my next section is titled "Racism," which, yeah, so the virus isn't spreading in this specific outbreak of monkey pox is been spreading in Nigeria since 2017. Yet, somehow there are no clinical...there's no clinical trial data of the effectiveness of the vaccine or T pox, which is the antiviral they've developed. No human studies. I wonder why. Um, well, I as I said it's understudied because up until now, it's been isolated to central and west Africa. Yeah. What would have happened if we were vaccinating on a large scale in Nigeria? Would it have spread? Margaret 40:31 Yeah, I mean, that's like such a thing that I keep thinking about all this shit, where it's like, it's just seemed so obvious to me that, like the solutions to all the major things that we're dealing with right now, like don't make any sense in a world full of borders. You know? Being like, like, "We got ours. Fuck you," doesn't make any fucking it never made any fucking sense. But, it really doesn't make any fucking sense now, or it's like, yeah, if we had, like, I don't understand, even if I'm like a self interested, rich white American. I don't understand how I can be like, "Oh, new new disease just dropped and it's in another country." Let's go get rid of it in another country. That makes sense from...it's cheaper than building spaceships to Mars. Brooke 41:16 I think it's people still just not fundamentally understanding how deeply integrated we are now as a global society. Yeah. I mean, we shouldn't have figured especially in the last couple of years, if you haven't figured it out before, then like, you should understand that now. I feel like... Margaret 41:32 Yeah, acids been around for a long time. Casandra 41:39 Don't understand the reference? Margaret 41:43 Just like, oh, no, like, we're all one consciousness? Whatever. Casandra 41:52 Okay, my next subsection of notes is titled "Homophobia." Margaret 41:55 Hurray. Casandra 41:56 This is...I'm announcing these by way of a content warning. So yeah, so I read a few different, you know, I've seen like on Twitter and stuff, people talking about how homophobia relates to the way the language the government has been using and media outlets have been using around monkeypox, and also the government response to it and didn't fully understand that other than that it's mainly spreading in queer networks right now. But, I read an article that talked about how the homophobia they were seeing was mainly around the language that gay sex is quote, unquote, 'driving' the epidemic. Yeah, and just like really sex negative advice around how to keep from getting monkey pox. But, in reality, the drivers of the epidemic are the structures globally that have led to like vaccines and tests and treatments all existing for this virus, but not being accessible. Margaret 42:57 Yeah. Casandra 42:58 Yeah, I don't know if y'all have read any of the first person accounts of people trying to find access even to a test. Like I read an account of someone who went to their doctor was like, "I think a monkey pox." and the doctor, like, had to jump through all of these hoops just to access a test Margaret 43:14 Fucking hell. Margaret 43:16 So that's cool. Let's see, before I talk about the 'What we can do,' I want to circle back to climate change really quickly. Because, I think that in my brain, I know that epidemics and climate change are related, but I hadn't thought much about how in the particular mechanisms, but I read an interview that, that interested in me a lot. And they talked about how climate change is driving the risk of infectious diseases. I saw a report that 58% of the 375 infectious diseases they examined, have...this is a quote, "have been at some point aggravated by 'climatic hazards.'" So that's cool. Brooke 44:03 I...but how? I don't understand the connection. Casandra 44:06 Yeah. So. So one way is that climate change, they were talking about how it brings humans closer to animals, not in the sense that like "We are closer to nature," but just like, as we encroach on... Brooke 44:17 oh, sure. Casandra 44:20 And so, animal to human transmission is a thing. But, also if we're talking about like climate change and natural disasters, people get very sick of diseases and die after natural disasters. So, I'm sure that's part of what they mean by 'aggravated,' being 'aggravated by climatic hazards.' Warmer temperatures also attract insects and carriers of disease to parts of the world that they didn't used to exist in. Margaret. I feel like you were talking about...we were talking the other night and you mentioned like...no was it you? Maybe I was reading something? I've been reading too much lately. I was reading about a type of mosquito that is like, more likely to carry things like Dengue fever, and is now in the US, is now in the northern hemisphere. And. Margaret 45:08 Oh, that's exciting. Casandra 45:10 Yeah, and it has to do with warmer water temperatures where they can hatch their eggs and also with capitalism, because apparently they were transported here in 'tires.' Margaret 45:22 Huh? Casandra 45:23 Like when tires sit, you know outside in a wash, tje water pools? Yeah. Wild. Margaret 45:33 Which ties back to rain catchment and how don't do lazy rain catchment where you just put your downspout into the barrel, you should filter it, and you should prevent mosquitoes from breeding in there. Also algae, and all kinds of other stuff. Casandra 45:47 Yeah, it's true. Brooke 45:49 So today's episode is brought to you by capitalism and racism. Margaret 45:54 And I was thinking rain barrels. But Sure. Brooke 45:59 Well, the reason we have to talk about these horrible things is the 'isms.' Margaret 46:04 Right? Where as I was thinking about sponsors, Big Rain Barrel. The big sponsor of the show. Brooke 46:11 That'd be a great sponsor. I hope we get a free barrel. Casandra 46:14 Yeah. Brooke 46:14 Free barrel with every Ep [episode] Margaret 46:16 Yeah. I want to be able to talk about them personally. So, please contact us through the site. The advertisers. I want the I want Big Rain Barrel to...I just want a rain barrel. That's all. Please continue. Casandra 46:31 So in 2022, we're still experiencing the COVID outbreak, right? And now my monkey pox. And also polio. Margaret 46:40 Cool. Casandra 46:42 Yeah. Yeah, yes. Polio. Someone Someone got polio. For the second time since they declared polio like a...they don't use the word eradicated. But they were basically like, "Humans don't get this anymore." But two have since then. One was this summer. So that's...okay. Brooke 47:06 That's neat. Casandra 47:07 Yeah, what can we do about it? We can wash our hands a lot. I'm still gonna wear a mask, even though the CDC says it's not airborne, because I don't understand the difference. And also Covid's still a thing. We can research testing and vaccination in our areas, because it seems to be vastly different in different cities and counties and really confusing. So you can do the research ahead of time and share it through your network so people know where to access information and help. You can also get vaccinated if you qualify. However, I let's see, I looked at a few different counties and their eligibility criteria. And they all seem to have a few things in common. You have to be gay or bisexual men, or a transgender person who has had either 1) Multiple or anonymous sex partners in the last 14 days or 2) Skin to skin, skin to skin or intimate contact with people at large venues or events in the last 14 days. And then they're also starting to include people of any gender or sexual orientation who have engaged in commercial or [cuts out], so sex workers in the last 14 days. So yeah, if any of those are you, and you have a vaccination place near you, why not get it? Margaret 48:32 Because Bill Gates will be able to track all the sex you have? Brooke 48:38 Yeah, Casandra 48:39 The reason I agreed to research monkey pox for this episode is because, like I said, my kids about to go back to school. And I was really nervous. And I'm feeling a little bit less nervous for the moment about school because of the cases documented in children so far areextremely low. So, that's some good news for all of the other parents out there. Margaret 49:02 And the children listening Casandra 49:05 For any of the children listening. Margaret 49:06 It just occurred to me that children might listen to this podcast. I'm so sorry, children, about the world. Not about the cussing. I'm sorry about the world. Casandra 49:18 Speaking of school, Brooke 49:20 Hey, yo, student loan forgiveness that's been in the news. Right? And as the person with the background in economics, I feel like I have to talk about that. So, student loans, I'm fairly certain that of the two of you one of you has student loans and one of you does not. And I'm I'm curious how each of you feel about student loan forgiveness without...you can go ahead and not reveal which one of you it is and isn't for the moment. Just tell me if you like it? Is it good? Or bad? Casandra 49:56 Fucking-tastic I mean, not this version, this version is just like so. So, but like, should they forgive all of our student loans? Fuck yes, they should. Margaret 50:04 I agree. Brooke 50:05 Casandra says yes. Oh, and Margaret agrees Wait, but only one of you has student loans? Margaret 50:11 So, I don't have student loans. And...I can't imagine, I can't imagine anyone who doesn't have student loans giving a shit. Like I just like, I struggle so hard. Like, every time someone's like, "They did this with our taxpayer money," and I'm like, "Motherfucker, they invaded half the world with our tax money." Like... Casandra 50:35 There there other things you should be frustrated about being done with your tax dollars. Casandra 50:40 And this is not one of them. Margaret 50:40 Yeah! Margaret 50:42 Yeah. And then even with my like, even if I was like a self interest capitalist shit, it's like, I don't know, healthy economy is not one built on fucking debt. And I don't know, whatever. I'm just like... Brooke 51:00 Don't spoil my ending, Margaret. Margaret 51:02 Oh, sorry. Right. Casandra 51:04 But capitalism means that there have to be people who are suffering and poor so that I can feel superior and be stable and have more money. Margaret 51:13 Oh, that's a good point. Casandra 51:14 Yeah. Margaret 51:15 No, I take it back actually, Brooke. I'd like to change my answer. No one should. Casandra 51:21 Fuck Casandra. Margaret 51:26 No one should have the right to have debt forgiven. It should probably be transmitted to children and children's children. Oh, wait, that already happens. Just okay. Anyway. Casandra 51:36 What about corporations? Shouldn't they be able to get their debt forgiven, Margaret? Margaret 51:40 Oh, yeah. I mean, corporations, obviously should have their debt forgiven. I mean, otherwise, we wouldn't have an economy. Brooke 51:46 Like, God. Okay. You two know everything. My work is done here. Throw the topic and walk away. Excellent. Casandra 51:55 Sorry, Brooke. Brooke 51:56 No, I'm loving it. Casandra 51:58 This is how we cope with talking about money. Margaret 52:01 Yeah. Brooke 52:04 Oh, it's so good. No, I have you know, I have a couple of, of friends and or relations that are both on the against it side. Well, neither of whom went to college or have any students debt. Casandra 52:21 Why are they still your friends? Brooke 52:22 Well, Facebook friends, let's say that. Casandra 52:25 That's fair. Brooke 52:25 I think it's important to listen to what people say on the other side. So, I try and understand the arguments and can have a conversation back and hopefully bring them into the light. Margaret 52:34 Yeah, that's legit. But wait, what if we instead created an increasingly more insular and pure subculture? Brooke 52:44 It seems problematic I'm gonna say, but... Margaret 52:47 What? Brooke 52:47 That's probably for another episode. Okay. Margaret 52:50 Okay, I'll stop derailing you, Casandra Johns 52:52 it would only be the three of us. Everyone else is wrong in some way. Margaret 52:56 I think that that's probably true. I'm sorry Bursts, who's doing our editing, I'm sorry Inmn, who produce the podcast. Brooke 53:06 You better apologize to all the patrons right now too. Margaret 53:10 Yeah, if you want to be pure and join our pure culture. A $20 a month level. Brooke 53:19 No. No cults. No cults. Margaret 53:22 Everyone keeps saying that to me. Okay. Brooke 53:26 That's why I took away that book on cults that I showed you the other day, you don't need the help. Margaret 53:32 Please continue. Brooke 53:33 Oh, God. Right. So so the arguments against it. Like you were saying, you know, one of them's about the, "I don't want my tax dollars going to that," which, like you said, is a pretty wild argument, because we don't get to decide directly where our tax dollars go. There's plenty of things that I'm in...None of us like taxes...And amongst us, especially like, abolish the government abolish the taxes, but even people who are okay with taxes as a functioning society, we still, you know, you don't get to decide where each dollar goes. What's your question face? Casandra 54:10 You mean when I vote, it doesn't directly change things? Brooke 54:14 Oh, God, another topic for another whole podcast episode about how about how it actually works out there in the world. Yeah, so that argument is kind of wild. And then the other one that I that I have seen is the, you know, "Why should anyone else pay for their choices?" especially if it's their...other people's bad choices or whatever. Which again, is wild to me. Margaret 54:42 You mean the bad choice to loan $60,000 to a 17 year old? Brooke 54:47 Yeah, seems like maybe that should be not a not a thing. Margaret 54:51 Well, I just but it's a bad financial like, like come on. That's that's a that's part of loaning money is you take into account like, there's risk involved. It is a risky loan to loan a 17 year old money. Anyway, yep. Sorry. Brooke 55:07 Yeah, I saw one of my, you know, probably Gen X or Boomer aged relatives saying, "Hey, I signed up for the loans at 18. And I read the document, and I knew what I was getting myself into. And it was a choice. And it's everybody's choice." And it's so many bad takes so many bad takes... Casandra 55:24 I wonder how much their loan was compared to mine? Brooke 55:27 Yeah, and there's that. Casandra 55:28 I'm gonna guess significantly less. Brooke 55:30 Yeah, so let me get into a little bit of data here, because I love data. Let's talk also about what the loans are and aren't, because if you're only looking at the headlines there's a lot that's not captured in there. The number we see tossed around is the $10,000 of forgiveness. And that's up to $10,000 of forgiveness. So there's caveats on that, because there's a income limitation as to when you can get it. And it decreases a little bit based on what your income is. But also, if you were awarded a Pell Grant, at any point in your college education, you can actually get up to $20,000 in forgiveness, and Pell Grants are a federal grant, not a loan, but a grant, i.e. a gift, basically, that only go out to the lowest income kind of folks. So, if you qualified for a Pell Grant at the time that you also took out loans, then you can get a higher amount of loan forgiveness. And then it also only is it takes effect for people who had taken out a loan prior to June 30th of this year 2020. So if you're in school, right now, if you're just starting this fall, it doesn't apply to you. You had to have taken out a loan prior to that to qualify. Some of the cool things about it, though, are that it helps kind of all kinds of federal loans, which 95% of student loan debt is a federal loan. Only about 5% is private loans. So that's most people with loans, although it's only again, those income requirements, but that's still a large portion of folks. Where's the other one I was looking at? Oh, there's a type of loans that parents can take out to help their kids. So most of the federal loans that folks sign up for, they are signing up themselves, right, you're putting yourself in debt for it, even though you're only 18, or whatever. But parents can also get a loan, there's a federal loan called Parent PLUS, that you can take out to help your kids and those loans also qualify for forgiveness. And that is different than the student's loan. So if you're a parent who took out one of those loans for your kid, and your kid also took out loans, you both separately qualify for forgiveness. Casandra 57:48 Is this...Sorry, is this...I hadn't heard of those parent loans. Is the thought that they're taking out a loan to help pay for their kids college? Brooke 57:56 Yeah. Casandra 57:57 Okay. So, just like, "Look, another loan we can give to someone." Brooke 58:02 Yeah. And it's a federal federal one again, and you know, federal loans overall are, at least compared with like private student loans you can get they're way more reasonable, super low interest rates, longer repayment periods, you can get restructuring, if you're having financial issues or get a pause on it, there's more ways to get them forgiven, like working for a nonprofit or in the private sector, stuff like that. So, these are sort of nicer loans, which is one of the faults that people point out with it is that the the private loans that are the more of the predatory style loans, like we talked about with the IMF earlier, you know, higher interest rates, they don't care about how much you are or aren't making necessarily, they just say you have to start paying it at this point, and you have to pay this much and they'll come after your car or your dog or your firstborn child or whatever in order to get their repayments. And this federal forgiveness doesn't affect those folks. Margaret 58:59 Would you say that our listeners should take out predatory loans from payday loan places in order to buy rain barrels? Brooke 59:08 No. Because you should never support predatory loan places. You can steall from those places. Margaret 59:16 What if we, what if we start a rain barrel loan fund that offers predatory rates? Brooke 59:28 Then I would no longer call you an anarchist. You'd be an An-Cap [Anarcho-capitalist] and out of the club. Casandra 59:33 Is this you? Is this you segwaying into an ad break for our sponsors? Margaret 59:41 No, i was my brain's poisoned by how the fact that my other podcast is...has actual ad breaks. Casandra 59:48 Duh Duh duh duuuuh! I'm rain barrels! Brooke 59:49 Hey, if rain barrels would give away some, loan some rain barrels, I would let them plug a little ad on this ad-free anarchist podcast network. Yeah. Margaret 1:00:01 Yeah. Although, I'm holding out for big IBC tote. Brooke 1:00:05 Yes. Margaret 1:00:05 Cause IBC totes are 275 gallons, sort of 55 gallons. And that's what I showered with for the past three years, an IBC tote available from wherever you're willing to go get a really cheap thing that used to be full of detergent and wash it out vaguely. Margaret 1:00:11 Half an hour's drive, we can go grab some. Casandra 1:00:25 Wait, really? Margaret 1:00:26 Yeah, yeah. Casandra 1:00:28 We should talk about that after we're done doing a podcast which we are in fact doing right now. Margaret 1:00:32 Oh right, okay. Brooke 1:00:33 Okay, one of the other things that comes up when folks talk about student loans is you get like the the Boomer types that will say, you know, "I worked a part time job when I was in school and paid off my...paid for my school while I was going to school." And I think we all know that that's just not possible to do anymore. And that's because of the cost of education and how it has skyrocketed. So, if you look at the difference from 70s, 80s, or so, of like median income in the US with the average household makes, versus the average cost of college, the average income has gone up like half again as much since the 80s or so, whereas the cost of college is four times more expensive than it was. And then the other argument that comes up that people make is, well, "Everybody thinks they have to go to college. Now, you know, everybody's trying to enroll in college, not everyone needs to go to college. But everyone tries to." And when you look at the numbers of like, the portion of the population that has that's going to college and how that's changed in the last like 50 years, it's been pretty much steady for the last 25 years. It rose in the 60s, late 60s was kind of flat in the 70s then started to rise again through the 80s and the mid 90s. Probably because of the series of recessions that we had that were really severe in some places, like Oregon had a really severe recession. And when there was a recession, more people go back to school, but it hit a peak in the mid 90s And then dropped for a while and then has kind of been staying around that peak, on average, over the last 25 years. That and that's the number of people has gone up, but the portion of the population, right, so as a percent of the total population has actually been quite stable for a while now. Margaret 1:02:30 And like, I'm a big fan of having not gotten a degree, right? But, I even had a dream again last night where I like dropped out of school again. And I was like, "Fuck you, I quit." And it was really, but, but it's something that I think that a lot of people don't talk about when they talk about being like, "Oh, well, not everyone needs a college degree," or whatever it is they they don't understand that like how important upper higher education is to upward mobility and upward class mobility, especially for like people who are like, marginalized among other identities besides class, like specifically around race, you know, like, there's...so I think that...I think it's something that we can accidentally get a little to like, "Yeah!" like, you know, people get very, like "I'm so blue collar, everyone should drive forklifts," instead of going and studying gender studies or whatever, right? And just like not fucking getting how important class mobility can be for people and how that functions most of the time. And so I get really annoyed when people are like, "No one should ever go to college," or whatever, because I'm like, that is a really that is a position that comes from a specific place for some people, you know? Casandra 1:03:44 Yeah. Brooke 1:03:46 I think people also forget in that the fact that college classes can include courses for some of those types of jobs. So,talking about like the other four year degree, an apprenticeship. You know, if you're an electrician or a sheetmetal worker, you're probably you're going to take some classes and probably through a community college as part of your education to get those kinds of jobs. If you're doing a forklift or CNC, you have to take a course and they can be three months, six months, twelve months courses, and often again, through community college. So even though you're not getting a degree, you're still doing some post secondary education. Margaret 1:04:29 Yeah. Casandra 1:04:30 Do you want to know how much debt I have for my community college? Brooke 1:04:34 Oh, this is gonna hurt. Casandra 1:04:36 Forty Grand. Brooke 1:04:38 Shut the front door. Casandra 1:04:41 And that's like with grants and shit because like I good grades and all that. I was on the 'President's list.' Brooke 1:04:45 For a frame of reference, listeners, Casandra graduated more recently, like last couple years, or three or whatever it was, but fairly recently. Yeah. When I was looking at the numbers, here's my personal anecdote. The cost have the four year degree that I got 15 years ago. I'm taking some community college classes now. And if I did an associate's degree, it would cost me as much for two years of community college today as it did for a four year degree with two majors 15 years ago. Yeah, the cost has has exponentially risen again. Four times. It's it's four times higher than it was like 40 years ago. It's risen more than anything, any other good or commodity. The cost of college has increased. Margaret 1:05:40 I will say, my, like optimistic, putting on my optimism hat. I don't like hats. That's probably why I'm not great. Okay. When I think about like some of the most...the strongest that leftist movements, anarchist movements, I know more about anarchist movements, I do other movements. The strongest they've been is like often, while popular education, or the existing educational infrastructure is failing everyone. And, you know, like a lot of work around reframing education in both France and Spain was coming out of anarchists in the late 19th and early 20th century in the modern school movement, all this stuff, and people were getting, like, literally murdered for advocating for things like "What if boys and girls are taught in the same classrooms and shit," and it's like awild idea that anarchists came up with. And like not talking about God in the classroom. Oh, my god, we're actually losing on all of these. Okay, anyway. It's like, "Remember the fight for an eight hour workday?" And I'm like, "Man, I wish I had eight hour workday right now." Okay, and but, but so that's like, my like, my, like, optimism is that like, in a burned for us new weeds grow? You know, I think that there's a lot of opportunity for alternative educational systems, but not in a way where they could like, immediately step in and be like an accredited university that allows the sort of class mobility that we're talking about, or whatever, right, but like, it does seem like mutual aid schooling and education are like, probably in a better position to take a foothold than they used to be. I hadn't really...I'd only previously thought about this more for like, grade school type stuff, especially for the whole, like how public school is like also kind of like low key just like childcare. And like, hadn't quite thought about this in terms of like, how it ties into, you know, continuing education, but it could, we could have Anarchy University, and then everyone could have degrees and okay, I don't know where I'm going with this. Brooke 1:07:45 Anarcho-U. Casandra 1:07:45 You need another project, Margaret. So... Margaret 1:07:51 No, dear listener, you need a project. At Projects-R-Us, we will give you a project. Brooke 1:08:00 Wrong podcast. Wrong, wrong podcast. Margaret 1:08:02 Replace the continuing education system!. Brooke 1:08:04 Nope, wrong podcast. Margaret 1:08:04 Okay, fine. Brooke 1:08:06 Yeah, so, Casandra 1:08:07 That'd be like your ideal job, I think. Margaret 1:08:09 it really would be, yes, I have way better at coming up with things that I can dedicate my entire life to than dedicating my entire life to any of the individual things. Brooke 1:08:22 Oh, maybe, maybe you didn't need to start the cult just to find leaders fo

Today is Wednesday, June 1, and we're looking at Bavarian Nordic vs. Moderna.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.